Skip Navigation Bar

History of Medicine Finding Aids

Medical Library Association Archives 1898-2002
full text File Size: 1883 K bytes | Add this to my bookbag

 
Box | Folder Title
 
Research Data PET Scans, 1953-2002, undated [subseries]:
 
Numbered, 1981, undated
50 1
1 autoradiograph with standard [photographs, negative], undated
50 2
2 DG + DG2 + MG molecules [photographs, negative], undated
50 3
3 DG through brain barrier [photographs, negative], undated
50 4
4 functional anatomy of operational -- *DG equ. [photographs, negative], undated
50 5
5 lumped constant in several species [photographs, negative], undated
50 6
6 glucose utilization in conscious rat and monkey [photographs, negative], undated
50 7
7 effects of thiopental anesthesia on cerebral glucose utilization [photographs, negative], undated
50 8
8 spinal cord effects of unilateral stimulation [photographs, negative], undated
50 9
9 relationship between frequency of stimulation and LGU [photographs, negatives, slides], undated
50 10
10 focal seizure during LGU [photographs, negatives], undated
50 11
11 otitis [photographs, negatives], undated
50 12
12 left eye removed (rat) L.G.U. [photographs, negatives], undated
50 13
13 coronal brain (monkey) [photographs, negatives], undated
50 14
14 coronal brain (monkey) -- rt. eye occluded, undated
50 15
15 [negative], undated
50 16
16 12 hr. lt./12 hr. dk. (glucose utilization) [photographs, negative], undated
50 17
17 apomorphine rt. eye enucleated [photographs, negative], undated
50 18
18 effects of d- and 1- amphetamine on LCGU in rat [photographs, negative], undated
50 19
19 computer diagram image display system [photographs, negative], undated
50 20
20 average brain cerebral glucose utilization [negative], undated
50 21
21 ageing and metabolism [photographs, negative], undated
50 22
22 ageing and metabolism [photographs, negative], undated
50 23
23 ageing and metabolism, LCGU vs. apomorphine [photographs, negative], undated
50 24
24 ageing, LCGU vs. apomorphine [photographs, negative], undated
50 25
25 LCGU vs. aopmorphine (subthalamic nucleus and inferior olivary nucleus) [photographs, negative], undated
50 26
26 LCGU vs. apomorphine (ageing) [photographs, negative], undated
50 27
27 DG, FDG, CH3 -- glucose, brain pictures [photographs, negative], undated
50 28
28 glucose metabolic rate (FDG) [photographs, negative], undated
50 29
29 LCGU vs. apomorphine (age), undated
50 30
30 LCBF w/[I125] Hipdm vs. [C14} idoantipyrine [photographs, negative], undated
50 31
31 LCBF indicator fraction method [photographs, negative], undated
50 32
32 spreading depression [photographs, negative], undated
50 33
33 [photographs, negative], undated
50 34
34 electrical stimulation and DG* uptake in pituitary [negative], undated
50 35
35 socium pump and neurosecretion effects on DG* uptake [photographs, negative], undated
50 36
36 [125] hipdm and products vs. radioactivity in arterial blood [photographs, negative], undated
50 37
37 radioactivity DPM vs. time curves [photographs, negative], undated
50 38
38 spreading cortical depression (KCI) [photographs, negative], 1981
50 39
39 osmotic opening of BBB [photographs, negative], undated
50 40
40 blood flow vs. LGU in conscious and anesthetized [photographs, negative], undated
50 41
41 [photographs, negative], undated
50 42
42 glucose utilization in dark-adapted rats (saline vs. apomorphine) [photographs, negative], undated
50 43
43 dark-adapted rats (eye enucleated) saline vs. apomorphine [photographs, negative], undated
50 44
44 effects of light intensity on LGU [photographs, negative], undated
50 45
45 [125I] hipdm single pass extraction vs. venous [photographs, negative], undated
50 46
46 deosyglucose vs. glucose in arterial and venous [photographs, negative], undated
50 47-48
47 influence of rate constants on integrated pool specific activity [photographs, negative], undated
50 49
48 rate constants in the normal conscious albino rat [negative], undated
50 50
49 lump constant vs. time [photographs, negative], undated
50 51
50 cerebral metabolism of [14C] DG and G in vivo [photographs, negative], undated
50 52
51 blood CO2 curves [photographs, negative], undated
50 53
52 striate cortex (monkey) [photographs, negative], undated
50 54
53 autoradiograph dorsolateral surface of monkey occipital lobe [photographs, negative], undated
50 55
54 LCGU vs. apomorphine [photograph, negative, slides], undated
50 56
55 systems involved in higher functions [negative], undated
50 57
56 auditory system (LCGU) [negative], undated
50 58
57 auxtomy, leucine protein synthesis [photographs, negative], undated
50 59
58 auxtomy, DG, protein synthesis nissl stain [photographs, negative], undated
50 60
59 3H and 24C DG [photographs, negative], undated
50 61
60 brain anatomy labeled [photographs, negative], undated
50 62
61 experimental period effects on gray matter glucose utilization [photographs, negative], undated
50 63
62 visual stimulus (3H] DG [photographs, negative], undated
50 64
63 pretectal nucleus [photographs, negative], undated
50 65
64 visual cortex [photographs, negative], undated
50 66
65 lateral geniculate nucleus [photographs, negative], undated
50 67
66 posterolateral nucleus of the thalamus [photographs, negative], undated
50 68
67 blood flow vs. LCGU (control) [photographs, negative], undated
50 69
68 blood flow vs. LCGU (acidosis) [photographs, negative], undated
50 70
69 blood flow vs. LCGU (acidosis and control) [photographs, negative], undated
50 71
70 antidromic stimulation of superior cervical ganglion [photographs, negative], undated
50 72
71 superior colliculus LCGU vs. light intensity [photographs, negative], undated
50 73
72 *DG and *DG-6-phosphate concentration over time [photographs, negative], undated
50 74
73 antidomic stimulation of superior cervical ganglion [photographs, negative], undated
50 75
74 antidromic stimulation of superior cervical ganglion [photographs, negative], undated
50 76
75 air embolism and control in K+ concentration [photographs, negative], undated
50 77
76 air embolism and control in pH of injection fluid [photographs, negative], undated
50 78
78 post axotomy and control [photographs, negative], undated
50 79
80 [photographs, negative], undated
50 80
81 hypoxemia [photographs, negative], undated
50 81
82 darkness vs. 700 lux (pigmented rats) [photographs, negative], undated
50 82
83 hypoxemia [photographs, negative], undated
50 83
84 hypoxemia [photographs, negative], undated
50 84
85 darkness vs. 700 lux (albino rats) [photographs, negative], undated
50 85
86 newborn monkey [photographs, negative], undated
50 86
87 [photographs, negative], undated
50 87
88 spinal cord [photographs, negative], undated
50 88
89 globus pallidus, etc. [negative], undated
50 89
90 reginal glucose utilization [photographs, negative], undated
50 90
91 reginal glucose metabolism after 10 min. cerebral ischemia in the rat [photographs, negative], undated
50 91
92 [photograph], undated
50 92
93 left eye removed [photographs, negative], undated
50 93
94 penn. seizure antipyrine, baby monkey [photographs, negative], undated
50 94
95 effects of thiopental anesthesia on cerebral glucose utilization [photograph], undated
50 95
97 equilibration of glucose specific activity between plasma and brain [photographs, negative], undated
50 96
98 influence of duration on glucose utilization [photographs, negative], undated
50 97
99 relationship between stimulation and L.G.U. [photographs, negative], undated
50 98
100 determination of glucose specific activity [photographs, negative], undated
50 99
101 brain-plasma glucose equilibration, undated
50 100
102 tissue glucose pool 1/2 life vs. plasma glucose concentration [photographs, negative], undated
50 101
103 glucose activity in plasma, tissue [negative], undated
50 102
104 cerebral 02 consumption in cerebral blood flow [photographs, negative], undated
50 103
105 half-lives of DG*-6-P in grey and white matter [photographs, negative], undated
50 104
106 arterial and venous [ ] of 14c D.G. following i.v. in a cat [photographs, negative], undated
50 105
107 derivation of operational method for measurement of LCGU [photographs, negative], undated
50 106
108 tissue pool 1/2 life [photographs, negative], undated
50 107
109 math. analysis of model for total accumulation of DG* and DG*-P [photograph, negative], undated
50 108
110 theoretical calculation of [14c] DG-6-P in rat brain [photographs], undated
50 109
111 general equation + influence of phosphotase activity [photograph, negative], undated
50 110
112 lumped constant calculation used by Hawkins and Miller [photographs], undated
50 111
113 [photograph], undated
50 112
114 equation for changing plasma glucose concentration [photograph, negative], undated
50 113
115 BBB model and equation of 14C glucose uptake [photograph, negative], undated
50 114
116 glucose uptake model + equation [photographs, negative], undated
50 115
117 LCGU in conscious albino and pigmented rats [negative], undated
50 116
118 glucose utilization in sensorimotor systems [negative], undated
50 117
119 glucose utilization in myelinated fiber tracts [negative], undated
50 118
120 glucose utilization in limbic system [negative], undated
50 119
121 glucose utilization in conscious and restrained rats [negative], undated
50 120
122 glucose utilization of the visual system [negative], undated
50 121
123 1/2 life of tissue pool in male rats [negative], undated
50 122
124 turnover of tissue glucose pool in male rats [negative], undated
50 123
125 values of rate constants in normal conscious albino rats [photographs, negative], undated
50 124
127 conditions w/altered function in CNS w/out change in average body metabolism [photograph], undated
50 125
128 relationship between consciousness and cerebral metabolic rate [photograph], undated
50 126
129 sodium pump and neurosecretion effects on DG* uptake, undated
50 127
130 functional anatomy of the DG*method equ. [photographs, negative, slide], undated
50 128
131 operational equation of [14C] DG method [photographs, negatives], undated
50 129
132 plasm -- tissue B-B-B (revised by Smith) [photographs, negatives], undated
50 130
135 LCBF with hipdm indicator fractionation method [photographs, negatives], undated
50 131
136 [14c] glucose-6-P single pass extraction fraction [photographs, negatives], undated
50 132
137 LCBF w/[I125] hipdm tissue equilibration method [photographs, negatives], undated
50 133
138 retinal stimulation in rats [photographs, negatives], undated
50 134
139 local cerebral glucose utilization [photographs, negatives], undated
50 135
140 local cerebral blood flow [photographs, negatives], undated
50 136
141 kinetics of competitive substrate reactions [photographs, negatives], undated
50 137
142 CBF and CMR 02 vs. years [photographs, negatives], undated
50 138
143 influence of CO2 in correlation between LCBF and LCGU [photographs, negatives], undated
50 139
144 monkey [photographs, negatives], undated
50 140
145 glucose utilization vs. stimulation frequency [photographs, negatives], undated
50 141
146 operational equation of [14C] deoxyglucose method [photograph], undated
50 142
147 cervical ganglion drawing [photographs, negatives], undated
51 1
148 cervical ganglion drawing [photographs, negatives], undated
51 2
149 cervical ganglion (micro) [photographs, negatives], undated
51 3
150 effects of apomorphine upon glucose utilization in habenula [photographs, negatives], undated
51 4
151 LCGU vs. halperidol [photographs, negatives], undated
51 5
152 LCGU vs. apomorphine [photographs, negatives], undated
51 6
153 preanglionic holinergic fibers [photographs, negatives], undated
51 7
154 pre-ganglionic cholinergic [photographs, negatives], undated
51 8
155 focal seizures -- protein synthesis [photographs, negatives], undated
51 9
156 focal seizures (metabolic effects) [photographs, negatives], undated
51 10
157 optical density, apomorphine vs. halperidol [photographs, negatives], undated
51 11
158 apomorphine vs. haloperidol (magnification) [photographs, negatives], undated
51 12
159 slide to side differences in monkey brain structures [photographs, negatives], undated
51 13
160 LGU in monkey brain [photographs, negatives], undated
51 14
161 influence of age on responsiveness to apomorphine [photographs, negatives], undated
51 15
162 influence of age on responsiveness to apomorphine (zona compacta) [photographs, negatives], undated
51 16
163 influence of age on responsiveness to apomorphine (aged 48-67) [photographs, negatives], undated
51 17
164 cervical ganglion [photographs, negatives], undated
51 18
165 regional glucose utilization [photographs, negatives], undated
51 19
166 regional glucose utilization (ketamine) [photographs, negatives], undated
51 20
167 regional glucose utilization (limbic system) [photographs, negatives], undated
51 21
168 regional glucose utilization: auditory, visual, sensory [photographs, negatives], undated
51 22
169 physiologic pearmeters [photographs, negatives], undated
51 23
170 LCGU (percentage change from control) [photographs, negatives], undated
51 24
171 LCGU (percentage change from control) ketamine [photographs, negatives], undated
51 25
172 blood flow transport and metabolism [photographs, negatives], undated
51 26
173 SSA vs. 1/[GHB] [photographs, negatives], undated
51 27
174 SSA or NADPH vs. 1/[NADP+] [photographs, negatives], undated
51 28
175 SSA or NADPH vs. time [photographs, negatives], undated
51 29
176 1/[GHB] vs NADPH, NADPH vs. 1/[NADPH] [photographs, negatives], undated
51 30
177 NADPH vs. 1/[NADPH] and 1/[GHD] [photographs, negatives], undated
51 31
178 SA vs. [GHB] and [D-glucuronate] [photographs, negatives], undated
51 32
179 apomorphine substantia nigra young vs. aged rats [photographs, negatives], undated
51 33
180 monocular deprivation (neonatal monkey) [photographs, negatives], undated
51 34
181 naftidro furyl [photographs, negatives], undated
51 35
182 hypoxemia metabolic raes [photographs, negatives], undated
51 36
183 lateral genic (monkey) [photographs, negatives], undated
51 37
184 ketamine [photographs, negatives], undated
51 38
185 norepinephrine vs. LCGU [photographs, negatives], undated
51 39
186 norepinephrine vs. control LCGU [photographs, negatives], undated
51 40
187 LCGU in white matter during hypoxemia [photographs, negatives], undated
51 41
188 awake/asleep, striate cortex and sensory-motor cortex [photographs, negatives], undated
51 42
189 lumped constant vs. plasma glucose [photographs, negatives], undated
51 43
190 superior cervical ganglia/glucose utilization [photographs, negatives], undated
51 44
191 coeliac and cardiac ganglia/glucose utilization [photographs, negatives], undated
51 45
192 hexokinase synthesis chart [photographs, negatives], undated
51 46
193 physiological variables in hypoxemia [photographs, negatives], undated
51 47
194 average rate of G.U. in whole brain during hypoxemia [photographs, negatives], undated
51 48
195 captopril effects on G. U. of subfornical organ in Brattleboro rats [photographs, negatives], undated
51 49
196 deoxyglucose autoradiographs of cat lumbar spinal cord [photographs, negatives], undated
51 50
197 lumbar spinal cord + brain autoradiographs and stained [photographs, negatives], undated
51 51
198 hyperglycemia lumped constant [photographs, negatives], undated
51 52
199 time course of arterial and venous concentrations of DG* and G [photographs, negatives], undated
51 53
200 model for behavior of leucine in brain [photographs, negatives], undated
51 54
201 glucose clamp [photographs, negatives], undated
51 55
202 lumped constant at different plasma glucose levels, undated
51 56
203 conversion of leucine to acetoacetic acid and acetyl-coenzyme A [photographs, negatives], undated
51 57
204 metabolic rates during hypoxemia [photographs, negatives], undated
51 58
205 axotomy hypoglossal nucleus [photographs, negatives], undated
51 59
206 derivation of operational equ.-model I [photographs, negatives], undated
51 60
207 behavior of leucine in brain model [photographs, negatives], undated
51 61
208 differential equations leucine [photographs, negatives], undated
51 62
209 behavior of leucine in brain model 2 [photographs, negatives], undated
51 63
210 differential equations leucine II [photographs, negatives], undated
51 64
211 derivation of operational equ. -- model III [photographs, negatives], undated
51 65
212 leucine brain -- model III [photographs, negatives], undated
51 66
213 differential equations model III [photographs, negatives], undated
51 67
214 derivation of operational equ. model III [photographs, negatives], undated
51 68
215 derivation of operational equ. III continued [photographs, negatives], undated
51 69
216 derivation of equation [photographs, negatives], undated
51 70
217 model IV -- amino acid incorporation into protein [photographs, negatives], undated
51 71
218 derivation of operational equ. model IV [photographs, negatives], undated
51 72
219 derivation of operational equ. -- model IV continued [photographs, negatives], undated
51 73
220 lumped constant in hypoglycemia [photographs, negatives], undated
51 74
221 DG model -- intracellular and extracellular spaces [photographs, negatives], undated
51 75
222 LCGU kates of insulin-induced hypoglycemia rats [photographs, negatives], undated
51 76
224 physiological variables during insulin-induced hypoglycemia [photographs, negatives], undated
51 77
225 determination of the 1/2 life of the precursor leucine pool [photographs, negatives], undated
51 78
226 synthesis and catabolism of histamine, undated
51 79
227 determination of activity of L-leucine and TRNA-bound leucine [photographs, negatives], undated
51 80
228 scheme for oxidation of [ ]-yydroxybutyrate/ reduction of D-glucuranate [photographs, negative], undated
51 81
229 superior cervical ganglia (G.U. vs. time) [photographs, negative], undated
51 82
230 synaptic mechanisms for histamine neurons [photographs, negative], undated
51 83
231 visual cortex of monkey [photographs], undated
51 84
232 fetal sheep [photographs, negative], undated
51 85
233 fetal sheep? [photographs, negative], undated
51 86
234 saphenous nerve stimulation during anesthesia [photographs, negative], undated
51 87
235 monkey columns [photographs, negative], undated
51 88
236 norepinephrine vs. control LCGU [photographs, negative], undated
51 89
237 autradiographic resolutions [photographs, negative], undated
51 90
239 layer thickness 3H activity [photographs, negative], undated
51 91
240 LandR hemisphere [photographs, negative], undated
51 92
241 functional anatomy of the operational equ. of the 14c DG method [photographs, negative], undated
51 93
242 [photographs, negative], undated
51 94
243 [photographs, negative], undated
51 95
244 [photographs, negative], undated
51 96
245 olfactory bulbs [photographs, negative], undated
51 97
246 relative optical density [photographs, negative], undated
51 98
247 hot hole plug [photographs, negative], undated
51 99
248 brain standards 3H and 14c [photographs, negative], undated
51 100
249 goldfish retinas [photographs, negative], undated
51 101
250 somata cells labeled and unlabeled [photographs, negative], undated
51 102
251 cat muscle, 24c DG [photographs, negative], undated
51 103
252 3H DG water solution frozen in plasma [photographs, negative], undated
51 104
253 grain density in buccal ganglion [photographs, negative], undated
51 105
254 olfactory bulb in tiger salamander 3HDG [photographs, negative], undated
51 106
255 3HDG -- optic lobes of dorsophila melanogaster [photographs, negative], undated
51 107
256 relationship of aggression to onset of lidocaine seizures [photographs, negative], undated
51 108
257 autoradiographic calibration curves vs 3H concentration [photographs, negative], undated
51 109
258 [photographs, negative], undated
51 110
259 occular dominance newborn [photographs, negative], undated
51 111
260 position-emitting atom [photographs, negative], undated
51 112
261 [14C] and [3H] methylglucose [photographs, negative], undated
51 113
262 mid and posterior hypothalamus [photographs, negative], undated
51 114
263 anterior hypothalamus [photographs, negative], undated
51 115
264 dopamine pathways [photographs, negative], undated
51 116
265 integrated tissue specific activity [photographs, negative], undated
51 117
266 energy metabolism in the hypothalamus: effects of reproductive hormones [photographs, negative], undated
51 118
267 integrated tissue sp. ac. [photographs, negative], undated
51 119
268 integrated tissue sp. ac. [photographs, negative], undated
51 120
269 integrated tissue sp. ac. [photographs, negative], undated
51 121
270 GHB-dehydrogenase [photographs, negative], undated
51 122
271 GHB-dehydrogenase [photographs, negative], undated
51 123
272 GHB-dehydrogenase [photographs, negative], undated
51 124
273 GHB-dehydrogenase [photographs, negative], undated
51 125
274 GHB-dehydrogenase [photographs, negative], undated
51 126
275 ESN and WFN, Italy (Smith) [negatives], undated
51 127
276 columns in striate cortex (monkey) [photographs, negatives], undated
51 128
278 computer -- block diagram, undated
51 129
279 hypoxic rat injected with black microspheres, undated
51 130
280 dopaminerglic systems influence [photographs, negative], undated
51 131
281 apomorphine vs. saline on LGU [photographs, negative], undated
51 132
282 ocular dominance columns in monkey [photographs, negative], undated
51 133
283 effects of slow-wave sleep on LGU [photographs, negative], undated
51 134
284 subfornical organ in Battleboro [photographs, negative], undated
51 135
285 neural lobe LGU [photographs, negative], undated
51 136
286 two compartment model for the behavior of leucine brain -- model V [photographs, negative], undated
51 137
287 model VI for behavior of L-leucine in brain [photographs, negative], undated
51 138
288 GHB and GABA levels in rat brain [photographs, negative], undated
51 139
289 cytosol -- rat [photographs, negative], undated
51 140
290 GHB levels -- rat kidney [photographs, negative], undated
51 141
291 GHB dehydrogenase activity in rat kidney [photographs, negative], undated
51 142
292 GHB -- dehydrogenase activity in rat brain [photographs, negative], undated
51 143
293 apomorphine effect on different areas [photographs, negative], undated
51 144
294 superior cervical ganglion -- frequency [photographs, negative], undated
51 145
295 lump constant theoretical derivations [photographs, negative], undated
51 146
296 comparison -- LGU with 3H DG and 14C DG [photographs, negative], undated
51 147
298 bar test after morphine [photographs, negative], undated
51 148
299 morphine effect on LGU in brain [photographs, negative], undated
51 149
300 morphine effect on LGU in brain [photographs, negative], undated
51 150
301 fetal sheep [photographs, negative], undated
51 151
302 fetal sheep [photographs, negative], undated
51 152
303 morphine vs. control tail flick [photographs, negative], undated
51 153
304 average rate of GU for entire brain of fetal and newborn sheep, undated
51 154
305 chemical analysis of 14C DG and 14C DG-L-P in normal rats [photographs, negative], undated
51 155
306 extinction -- Icss [photographs, negative], undated
51 156
307 PCO2 and LCGU relationship [photographs, negative], undated
51 157
308 habenula afferent and efferent pathways [photographs, negative], undated
51 158
309 LGU in laboratory animals [photographs, negative], undated
51 159
310 time course of 14C DG and 14C DG-6-P [photographs, negative], undated
51 160
311 LGU and arterial PCO2 relationship [photographs, negative], undated
51 161
312 habenula and mammillary baby pathways [photographs, negative], undated
51 162
313 lateral habenula and mammillary baby pathways [photographs, negative], undated
51 163
314 [14C] deoxyglucose autoradiographs of cat brains [photographs, negative], undated
51 164
315 effect of acute morphine on GU in rat brain [photographs, negative], undated
51 165
315 effect of acute morphine on GU in rat brain [photographs, negative], undated
51 166
316 fetal sheep [photographs], undated
51 167
317 picture procedure, DG method [photographs, negative], undated
51 168
318 axotomy in hypoglossal nucleus [photographs, negative], undated
51 169
319 axotomy -- tongue functions [photographs, negative], undated
51 170
320 age-blood flow and 02 consumption [photographs, negative], undated
51 171
321 exchange of methylglucose between plasma and brain tissue [photographs, negative], undated
51 172
322 data analysis -- ipsilateral vs. contralateral [photographs, negative], undated
51 173
323 LGU stimulation pathway [photographs, negative], undated
51 174
324 3H standards calibration curves [photographs, negative], undated
51 175
325 visual deprivation protein synthesis [photographs, negative], undated
52 1
326 autoradiograph protein synthesis [photographs, negative], undated
52 2
327 LGU other connections [photographs, negative], undated
52 3
328 LGU: sensory-motor systems [photographs, negative], undated
52 4
329 LGU: forebrain terminal areas [photographs, negative], undated
52 5
330 electrode placements: contingent and non-contingent [photographs, negative], undated
52 6
331 electrode placements: stimulated and non-stimulated [photographs, negative], undated
52 7
332 3H methylglucose vs. 14C methylglucose [photographs, negative], undated
52 8
333 3H DG vs. 14C DG [photographs, negative], undated
52 9
334 morphine bar test and tail flick [photographs, negative], undated
52 10
335 [photographs, negative], undated
52 11
336 pineal body -- LGU monkey [photographs, negative], undated
52 12
337 diazepam -- LGU [photographs, negative], undated
52 13
338 TXW vs. control [photographs, negative], undated
52 14
339 cretin vs. control [photographs, negative], undated
52 15
340 TWX vs. control [photographs, negative], undated
52 16
341 physiological parameters -- day vs. night and sleep vs. awake [photographs, negative], undated
52 17
342 lesion -- lateral habenula -- LGU [photographs, negative], undated
52 18
343 fetal sheep [photographs, negative], undated
52 19
344 LGU in lateral habenula [photographs, negative], undated
52 20
348 GHB -- anaerobic and aerobic [photographs, negative], undated
52 21
349 neural structures regulating fluid balance [photographs, negative], undated
52 22
350 GHB dehydrogenase inhibitors on tissue levels of GHB [photographs, negative], undated
52 23
351 GHB -- synthesis and degradations pathways [photographs, negative], undated
52 24
352 distribution of radioactivity after various stages of fractionation [photographs, negative], undated
52 25
353 distribution of brain glycogen among fractions after extraction [photographs, negative], undated
52 26
354 brain extraction scheme 1 [photographs, negative], undated
52 27
355 brain extraction scheme 2 [photographs, negative], undated
52 28
356 histaminergic sites influence on cerebral vessels [photographs, negative], undated
52 29
357 neurotransmitter substances -- effect on pial arteriolar diameter [photographs, negative], undated
52 30
358 encaphalocoele vs. control, striate cortex of monkey [photographs, negative], undated
52 31
359 insulin -- effect on LGU [photographs, negative], undated
52 32
360 hyperglycemia vs. normal -- LGU [photographs, negative], undated
52 33
361 2-DG-6-PO4 and 2 DG-TLC of brain extracts [photographs, negative], undated
52 34
362 LGU in ganglia during stimulation (H2) in urethane anesthesia [photographs, negative], undated
52 35
363 probe track [photographs, negative], undated
52 36
364 VTA stimulation [photographs, negative], undated
52 37
365 VTA stimulation [photographs, negative], undated
52 38
366 amphetamine -- LGU [photographs, negative], undated
52 39
367 amphetamine -- locomotor and stereotypy scores [photographs, negative], undated
52 40
368 amphetamine [photographs, negative], undated
52 41
369 amphetamine [photographs, negative], undated
52 42
370 amphetamine [photographs, negative], undated
52 43
371 angiotensis II and saralasin [photographs, negative], undated
52 44
372 angiotensinard saralasin [photographs, negative], undated
52 45
373 apomorphine [photographs, negative], undated
52 46
374 apomorphine [photographs, negative], undated
52 47
375 subfornical organ and septal triangular N. -- LGU [photographs, negative], undated
52 48
376 subformical organ and septal tricular N. -- LGU [photographs, negative], undated
52 49
377 sheep LCGU -- pre and postnatal [photographs, negative], undated
52 50
378 caffeine -- LGU [photographs, negative], undated
52 51
379 caffeine -- LGU [photographs, negative], undated
52 52
380 EAS [photographs, negative], undated
52 53
381 female rats during cycle [photographs, negative], undated
52 54
382 electrical stimulation on pineal gland [photographs, negative], undated
52 55
383 female rats during cycle [photographs, negative], undated
52 56
384 model I -- leucine traveling BBB [photographs, negative], undated
52 57
385 percent change of protein synthesis, glucose utilization and relative twitch [photographs, negative], undated
52 58
386 glucose utilization in menstruating rats [photographs, negative], undated
52 59
387 postral calcarin fissure [photographs, negative], undated
52 60
388 optic radiation tract section [photographs, negative], undated
52 61
389 eye occlusion striate cortex [photographs, negative], undated
52 62
390 ambient light markings, striate cortex [photographs, negative], undated
52 63
391 eye occlusion lateral geniculate [photographs, negative], undated
52 64
392 general equ. for measurement of reaction rates with tracers [photographs, negative], undated
52 65
394 [125I] HIPDM and metabolic products in blood [photographs, negative], undated
52 66
395 molecular structure of HIPDM [photographs, negative], undated
52 67
396 [125I] HIPDM single pass extraction [photographs, negative], undated
52 68
397 super optical nucleus, salt loading [photographs, negative], undated
52 69
398 senescence [photographs, negative], undated
52 70
399 maturescence [photographs, negative], undated
52 71
400 LGU % change vs. stimulation frequency [photographs, negative], undated
52 72
401 sciatic nerve stim. LGU in spinal cord and dorsal root ganglia [photographs, negative], undated
52 73
402 water saturated vs. water deprived [photographs, negative], undated
52 74
403 water sated vs. H2O deprived [photographs, negative], undated
52 75
404 water sated vs. H2O deprived [photographs, negative], undated
52 76
405 self-stimulation chapter [photographs, negative], undated
52 77
406 self stim. cocaine/d-amphetamine/morphine [photographs, negative], undated
52 78
407 criteria for adequate psychophysical threshold determination [photographs, negative], undated
52 79
408 self stimulation [photographs, negative], undated
52 80
409 self stim. % response vs. ua [photographs, negative], undated
52 81
410 self stim. X Z score vs. dose [photographs, negative], undated
52 82
411 running speed vs. log pulses per reward [photographs, negative], undated
52 83
412 self-stimulation (graphic) [photographs, negative], undated
52 84
413 response rate vs. intensity (base line drug) [photographs, negative], undated
52 85
414a self stimulation pre/post responses [photographs, negative], undated
52 86
414b acute dehydration [photographs, negative], undated
52 87
415 acute dehydration [photographs, negative], undated
52 88
416 (spinal cord ) acute dehydration [photographs, negative], undated
52 89
417 adrenelectomy and dexamethason [photographs, negative], undated
52 90
418 nerve stimulation -- dorsal root ganglion [photographs, negative], undated
52 91
419 paraventricular nucleus -- acute adrenalectomy [photographs, negative], undated
52 92
420 dehydration [photographs, negative], undated
52 93
421 plasma and brain, deoxyglucose and deoxyglucose -- phosphate [photographs, negative], undated
52 94
422 arterial plasma DG*/G vs. time [photographs, negative], undated
52 95
423 pituitary neural lobe, water sated/water deprived [photographs, negative], undated
52 96
424 septal triangular nucleus [negative], undated
52 97
425 subfornical organ [photographs, negative], undated
52 98
426 latero-lateral habenula [photographs, negative], undated
52 99
427 spinal cord sciatic nerve stimulation [photographs, negative], undated
52 100
428 plasma concentration (arterial and venous) vs. time [photographs, negative], undated
52 101
429 pathways of glucose metabolism [photographs, negative], undated
52 102
430 uptake of [32P] glucose-6-phosphate [photographs, negative], undated
52 103
431 loss of label rates of [2-3H] glucose and [U14C] glucose in brain [photographs, negative], undated
52 104
432 electrical stim. of sciatic nerve on LGU in spinal cord [photographs, negative], undated
52 105
433 fractions of total tissue 14c content in form of free [14c] deoxyglucose in brain [photographs, negative], undated
52 106
434 time courses of [14c] DG and 14c DG-6-P, undated
52 107
435 measured and theoretical time courses of [14c] DG-6-P in brain [photographs, negative], undated
52 108
436 arteriovenous differences of [14c] glucose and [14c] DG [photographs, negative], undated
52 109
437 newborn lamb [photographs, negative], undated
52 110
438 comparative rates of loss of label from 2-[3H] glucose and, undated
52 111
439 nonacidic compounds w/vicinal cis diol. Groups [photographs, negative], undated
52 112
442 effects of fasting on tissue levels of GHB [photographs, negative], undated
52 113
443 biosynthesis of GHB by intact mitochondria [photographs, negative], undated
52 114
444 rates of glucose utilization in rat cervical ganglion [photographs, negative], undated
52 115
445 representative values for LCGU in conscious albino rat and monkey, undated
52 116
446 [photographs, negative], undated
52 117
447 cretin vs. control [photographs, negative], undated
52 118
448 parasaggittal blindspot [photographs, negative], undated
52 119
449 cretin vs. control [photographs, negative], undated
52 120
450 cretin vs. control [photographs, negative], undated
52 121
451 refused monkey cortical section [photographs, negative], undated
52 122
454 E-cat scan of normal brain after injection of [18-F] fluorodeoxyglucose[photographs, negative], undated
52 123
455 [photographs, negative], undated
52 124
456 3H/14C ration in blood glucose [photographs, negative], undated
52 125
457 pathways of GHB metabolism [photographs, negative], undated
52 126
458 LGU in cervical ganglion [photographs, negative], undated
52 127
459 [photographs, negative], undated
52 128
460 simulation effects of frequency on LGU [photographs, negative], undated
52 129
461 effects of acute dehydration on LBG in subfornical organ [photographs, negative], undated
52 130
462 effects of acute dehydration on LGU in paracentricular nucleus [photographs, negative], undated
52 131
463 effects of DD AVP on LGU of septaltriangular nucleus [photographs, negative], undated
52 132
464 effects of DD AVP on LGU of lateral habenula nucleus, subfornical organ and paracentricular nucleus [photographs, negative], undated
52 133
465 Krebs cycle [photographs, negative], undated
52 134
466 Krebs cycles [photographs, negative], undated
52 135
467 metabolism of carbohydrates [photographs, negative], undated
52 136
468 metabolism of carbohydrate w/2-DG and 2-DG-6-P [photographs, negative], undated
52 137
469 [photograph], undated
52 138
470 G-6-P derivative of glucose fraction separated by chromatography [photographs, negative], undated
52 139
471 separation of glucose by column and paper chromatography [photographs, negative], undated
52 140
472 MPTP and L-DOPA [photographs, negative], undated
52 141
473 MPTP and L-DOPA [photographs, negative], undated
52 142
474 Estrus cycle [photographs, negative], undated
52 143
475 dose dependent of methylphoedine [photographs, negative], undated
52 144
476 DPTP and L-DOPA [photographs, negative], undated
52 145
477 G-6-P and DG-6-P activities in rat tissues [photographs, negative], undated
52 146
478 LGU in iodomethacin and dexamethasone [photographs, negative], undated
52 147
479 radiochemical heterogeneity of eluate in Dowex-1-borate column [photographs, negative], undated
52 148
480 theoretical time courses of [14c] DG-6-P in brain [photographs, negative], undated
52 149
481 glucose-6-[32p] phosphate arterial and cerebral venous concentrations [photographs, negative], undated
52 150
482 [14c] G-6-P single pass extraction fraction, undated
52 151
484 time courses of [14C] DG and [14C] DG-6-P [photographs, negative], undated
52 152
485 effects of antidromic stimulation on the rates of glucose utilization [photographs, negative], undated
53 1
486 plasma concentration vs. rate constants [photographs, negative], undated
53 2
487 difference in glucose utilization vs. frequency of stimulation (Hz) [photographs, negative], undated
53 3
488 plasma glucose concentration vs. glucose infusion rate [photographs, negative], undated
53 4
489 lumped constant at different plasma glucose levels [photographs, negative], undated
53 5
490 arterial and venous concentrations [photographs, negative], undated
53 6
491 self stimulation [photographs, negative], undated
53 7
492 self stimulation II [photographs, negative], undated
53 8
493 LGN in intact binocular vision vs. chronic monocular deprivation [photographs, negative], undated
53 9
494 dorsal root ganglion [photographs, negative], undated
53 10
495 monkey arm movement [photographs], undated
53 11
496 estimation of rate constants for dephosphorylation [photographs, negative], undated
53 12
497 LCGU in globus pallidus and subthalmic nucleus [photographs, negative], undated
53 13
498 DG6P by NMR vs. DG6P [GC-MS] [photographs, negative], undated
53 14
499 LCGU in sensorimotor cortex and ventromedial thalamus [photographs, negative], undated
53 15
500 LCGU [photographs, negative], undated
53 16
501 % change in G.U. from no stimulation control values [photographs, negative], undated
53 17
502 % change in G.U. from no stimulation control values [photographs, negative], undated
53 18
503 % change in GU (IPSI vs. contralateral) [photographs, negative], undated
53 19
504 LCGU in medial prefrontal and anterior cingulated cortex [photographs, negative], undated
53 20
505 % change in GU, anterior cingulated and dorsomedial caudate [photographs, negative], undated
53 21
506 changes in metabolic activity during self-stimulation [photographs, negative], undated
53 22
507 behaviors associated w/self-stimulation to the ventral mid brain [photographs, negative], undated
53 23
508 concentrations of glucose, glycogen and lactate [photographs, negative], undated
53 24
509 [14c] DG concentration in plasma, gray and white [photographs, negative], undated
53 25
510 % of 14c as 14c-DG/amount of 14c-DGP found after single injection [photographs, negative], undated
53 26
511 principle of the assay of glucose-6-P in vivo by selective detritiation of [2-3H]G [photographs, negative], undated
53 27
512 incorporation of 2-[14c] deoxyglucose into glycogen a [photographs, negative], undated
53 28
513 GU in control post-radiation: 4 days and 4 weeks [photographs, slides], undated
53 29
514 glucose infusion rate[photographs, negative], undated
53 30
515 lumped constant vs. arterial plasma glucose [photographs, negative], undated
53 31
516 arterial plasma glucose concentration vs. duration of infusion [photographs, negative], undated
53 32
517 determination of lumped constants during hyperglycemia state [photographs, negative], undated
53 33
518 arterial plasma glucose concentration vs. rate constants in grey and white matter [photographs, negative], undated
53 34
519 lumped constant vs. arterial plasma glucose concentration [photographs, negative], undated
53 35
520 lack of uptake of [32p] G-6-P [photographs, negative], undated
53 36
521 Hawkins brain, DG-6-P graphs [photographs, negative], undated
53 37
522 stimulation of sciatic nerve [photographs, negative], undated
53 38
523 cytochemical localization of G-6-P [photographs, negative], undated
53 39
524 localization of G6-pase in a nerve cell [photographs, negative], undated
53 40
525 effects of catecholamines of cerebral circulation and metabolism [photographs, negative], undated
53 41
526 eye occlusion striate cortex [photographs, negative], undated
53 42
527 control, Tx and Tx + warm [photographs, negative], undated
53 43
528 effects of amphetamines on brain glucose metabolism D [photographs, negative], undated
53 44
530 Ci*/cp* vs. real time (square wave experiment) [photographs, negative], undated
53 45
531 influence of duration of experimental period on weighted ave G.U. [photographs, negative], undated
53 46
532 Ci*/Cp* vs. stretch time [photographs, negative], undated
53 47
533 Ci*/Cp* vs. real time [photographs, negative], undated
53 48
534 operational equation with 5 rate constants [photographs, negative], undated
53 49
535 LCGU vs. methylphenidate [photographs, negative], undated
53 50
536 methlyphenidate [photographs, negative], undated
53 51
537 LCGU vs. methylphenidate [photographs, negative], undated
53 52
538 the localization of G-6-pase in nerve cell of cerebral cortex [photographs, negative], undated
53 53
540 G-6-P localization in liver [photographs, negative], undated
53 54
541 effects of L-DOPA treatment on LCGU [photographs, negative], undated
53 55
542 L-DOPA effects on LCGU in normal and MPTP-treated monkeys [photographs, negative], undated
53 56
543 % dephosphorylation vs. % dephosphorylation of DG-6-P [photographs, negative], undated
53 57
544 stretch time vs. apparent distribution space in sensorimotor cortex [photographs, negative], undated
53 58
545 weighted average tissue concentration [photographs, negative], undated
53 59
546 Ci*(T)/Cp*(T) vs. stretch time in sensory cortex [photographs, negative], undated
53 60
547 Ci*(T)/Cp*(T) vs. stretch time in hypothalamus [photographs, negative], undated
53 61
548 substantia nigra (pars reticulate) [photographs, negative], undated
53 62
549 N20 VOI % vs. min. of inhalation [photographs, negative], undated
53 63
550 apparent distributions space vs. real time [photographs, negative], undated
53 64
551 Ci*(T)/Cp* vs. real time (square wave experiments) [photographs, negative], undated
53 65
552 body temp. vs. time (min. after injection) [photographs, negative], undated
53 66
553 N moles GHB/g brain vs. dose of GHB (mg/kg) [photographs, negative], undated
53 67
554 t (C at 0-60 min.) vs. dose of GHB (mg/kg) [photographs, negative], undated
53 68
555 cerebral and cerebellar cortex [photographs, negative], undated
53 69
556 white matter structures [photographs, negative], undated
53 70
557 % error of prediction: s. colliculus, pontine gray matter and sunstantia nigra [photographs, negative], undated
53 71
558 deep cerebral gray structures [photographs, negative], undated
53 72
559 effect of L-gulonate or D-glucuronate in plasma disappearance curve (GHB) [photographs, negative], undated
53 73
560 weighted LCGU vs. time conc. rem sleep [photographs, negative], undated
53 74
561 % error of prediction [photographs, negative], undated
53 75
562 rate constants [photographs, negative], undated
53 76
563 model and equa. for estimation of rate constants for dephosphorylation [photographs, negative], undated
53 77
565 weighted average tissue concentration [photographs, negative], undated
53 78
566 pontine gray [photographs, negative], undated
53 79
567 globus pallidus [photographs, negative], undated
53 80
568 cerebellar cortex [photographs, negative], undated
53 81
569 corpus callosum [photographs, negative], undated
53 82
570 arterial plasma concentration [photographs, negative], undated
53 83
571 arterial plasma concentration [photographs, negative], undated
53 84
572 sensory cortex [photographs, negative], undated
53 85
573 influence of duration of experimental period on weighted ave. G.U. [photographs, negative], undated
53 86
574 total DG-6-P concentration, undated
53 87
575 concentration -- weighted fraction of total time spent in rem sleep [photographs, negative], undated
53 88
576 [14c] DG concentration vs. time [photographs, negative], undated
53 89
577 relative 3H/14c (sample/injectant) [photographs, negative], undated
53 90
578 labeled compounds remaining after hexokinase purification step [photographs, negative], undated
53 91
579 pyrrolidone-5-carboxylate is a major contaminant of huang and veech ?��glucose' [photographs, negative], undated
53 92
580 % total DPM and relative 3H/14C ratio [photographs, negative], undated
53 93
581 labeled contaminants in huang and veech ?��glucose' [photographs, negative], undated
53 94
582 lability of [2-3H, U-14C] glucose during purification, undated
53 95
583 labeled compounds remaining after glucose oxidase purification step [photographs, negative], undated
53 96
584 glucose purification [photographs, negative], undated
53 97
585, undated
53 98
586 LCGU in rem sleep [photographs, negative], undated
53 99
587 LCGU vs. time concentration slow wave sleep [photographs, negative], undated
53 100
588 washout correction experiment [photographs, negative], undated
53 101
589 ulisse [photographs, negative], undated
53 102
590 ulisse [photographs, negative], undated
53 103
591 ulisse [photographs, negative], undated
53 104
592 ulisse [photographs, negative], undated
53 105
593 pet scan -- Italian [photographs, negative], undated
53 106
594 cerebellar cortex [photographs, negative], undated
53 107
595 internal capsule [photographs, negative], undated
53 108
596 tissue 2DG and 2DG-6-P, undated
53 109
597 relationship between cerebral oxygen consumption and G.U. [photographs, negative], undated
53 110
598 body temp. vs. time [photographs, negative], undated
53 111
599 lumped constant in several species [photographs, negative], undated
53 112
600 rate constants for 3-0-methylglucose [photographs, negative], undated
53 113
601 ratio of antibody to cytosol or to homogenate [photographs, negative], undated
53 114
602 rate constants for dephosphorylation [photographs, negative], undated
53 115
603 blood flow vs. age [photographs, negative], undated
53 116
604 patlak plot [photographs, negative], undated
53 117
605 equa. for estimation of rate constants for dephosphorylation [photographs, negative], undated
53 118
606 GH B in cytosol [photographs, negative], undated
53 119
607 GHB dehydrogenase vs. sod. valproate [photographs, negative], undated
53 120
608 brain growth in different species in relation to birth [photographs, negative], undated
53 121
609 parkisonian syndrome [photographs, negative], undated
53 122
610 [14C] DG and [14C] DG-6-P concentration vs. time [photographs, negative], undated
53 123
612 theoretical calculation of [14C] DG-6- P [photographs, negative], undated
53 124
613 2 DG and rem sleep [photographs, negative], undated
53 125
614 GHB activity vs. time [photographs, negative], undated
53 126
615 time course of average brain DG-6-P concentration [photographs, negative], undated
53 127
616 DG-6-P glucose clamp [photographs, negative], undated
53 128
617 futile cycle associated w/ G6P (G6 pase) [photographs, negative], undated
53 129
618 Huang and Beech TLC contaminants [photographs, negative], undated
53 130
619 L-DG and enzyme [photographs, negative], undated
53 131
620 SSA formed vs. pH [photographs, negative], undated
53 132
621 SSA and [symbol] -- KG [photographs, negative], undated
53 133
622 [symbol] -- KG, GHB and enzyme [photographs, negative], undated
53 134
623 plasma glucose in normoglycemia [photographs, negative], undated
53 135
625 plasma glucose in hyperglycemia [photographs, negative], undated
53 136
626 pulse and square wave in S. N. [photographs, negative], undated
53 137
627 pulse and sq. wave in sensory cortex [photographs, negative], undated
53 138
628 pulse and sq. wave in dorsal thalamus [photographs, negative], undated
53 139
629 pulse and sq. wave in whole brain [photographs, negative], undated
53 140
630 pulse and sq. wave in cerebellar cortex [photographs, negative], undated
53 141
631 pulse and sq. wave in hypothalamus [photographs, negative], undated
53 142
632 pulse and sq. wave in internal capsule [photographs, negative], undated
53 143
633 L-hydroxyglutaric acid TMS [photographs, negative], undated
53 144
634 V-hydroxybutyric acid vs. temp. [photographs, negative], undated
53 145
635 veech contaminants [photographs, negative], undated
53 146
636 pontine gray (Pulse and SQ. Wave) [photographs, negative], undated
53 147
637 plasma glucose in hypoglycemia [photographs, negative], undated
53 148
638 veech column separation [photographs, negative], undated
53 149
639 glucose utilization in sq. wave [photographs, negative], undated
53 150
640 duration of experimental period on weighted G.U. (pulse) [photographs, negative], undated
53 151
641 after derivatization of glucose w/ hexokinase and G. oxidase [photographs, negative], undated
53 152
642 veech analysis of contaminants [photographs, negative], undated
53 153
643 brain extract -- dowex (Veech) [photographs, negative], undated
53 154
644 veech contaminants after separation [photographs, negative], undated
53 155
645 plasma glucose vs. pulse and sq. wave [photographs, negative], undated
53 156
646 rate constants vs. length of experiment [photographs, negative], undated
53 157
647 CBF in normal mouse [photographs, negative], undated
53 158
648 plasma glucose concentration in normoglycemia[photographs, negative], undated
53 159
649 plasma glucose concentration in hypoglycemia [photographs, negative], undated
53 160
650 plasma glucose concentration in hyperglycemia, undated
54 1
651 cocaine / activity [photographs, negative], undated
54 2
652 cocaine -- gluc. Util. vs. activity [photographs, negative], undated
54 3
653 acute MPTP : olive [photographs, negative], undated
54 4
654 MPTP acute : nigra [photographs, negative], undated
54 5
655 mouse blood flow [photographs, negative], undated
54 6
656 arithmetic average rate constants [photographs, negative], undated
54 7
657 hypothalamus [photographs, negative], undated
54 8
658 substantia nigra reticulata [photographs, negative], undated
54 9
659 rate constants determined for cerebellar cortex [photographs, negative], undated
54 10
660 rate constants -- SN ret. [photographs, negative], undated
54 11
661 constants -- internal capsule [photographs, negative], undated
54 12
662 rate constants -- hypothalamus [photographs, negative], undated
54 13
663 arithmetic average rate constants for white matter [photographs, negative], undated
54 14
664 mouse blood flow rate corrections [photographs, negative], undated
54 15
665 LCBF VS. LCGU in normal mice [photographs, negative], undated
54 16
666 LCBF VS. LCGU in normal mice [photographs, negative], undated
54 17
667 cocaine -- activity vs. time after 2 DG. [photographs, negative], undated
54 18
668 rate constants -- composite [photographs, negative], undated
54 19
669 metabolites -- dowex -- 1 -- formate column [photographs, negative], undated
54 20
670 methyl glucose plasma concentration vs. time [photographs, negative], undated
54 21
671 elution of methylglucose [14C] vs. [U -- 14C ] [photographs, negative], undated
54 22
672 hexokinase on dowex -- 1 -- formate effluent [photographs, negative], undated
54 23
673 plasma glucose on dowex in normoglycemia and hyperglycemia [photographs, negative], undated
54 24
674 cocaine LCGU vs. dose [photographs, negative], undated
54 25
675 drugs and LCGU [photographs, negative], undated
54 26
676 cocaine -- LCGU in nucl. acc. and SN.[photographs, negative], undated
54 27
677 neurotransmitters and basal ganglia [photographs, negative], undated
54 28
678 main connections of the nigrostriatal system [photographs, negative], undated
54 29
679 diagram of basal ganglia [photographs, negative], undated
54 30
680 [photographs, negative], undated
54 31
682 hypergly. methyl glucose [photographs, negative], undated
54 32
683 extractions of sugars [photographs, negative], undated
54 33
684 % of 14C applied to dowex -- 1 -- formate column [photographs, negative], undated
54 34
685 extraction of metabolites [photographs, negative], undated
54 35
686 diagram of precursor pool [photographs, negative], undated
54 36
687 10K model [photographs, negative], undated
54 37
688 plasma glucose in hyperglycemia [photographs, negative], undated
54 38
689 plasma glucose in normoglycemia [photographs, negative], undated
54 39
690 plasma glucose in hypoglycemia [photographs, negative], undated
54 40
691 5 rate constants model [photographs, negative], undated
54 41
692 fractional rate of product loss [photographs, negative], undated
54 42
693 LCGU vs. med. geniculate [photographs, negative], undated
54 43
694 triopental and celiac ganglionectomy [photographs, negative], undated
54 44
695 Gl. util. thiopental and celiac ganglionectomy [photographs, negative], undated
54 45
696 G.U. thiopental and celiac ganglionectomy [photographs, negative], undated
54 46
697 G.U. thiopental and celiac ganglionectomy [photographs, negative], undated
54 47
698 lumped constants in normo and hypo glycemia [photographs, negative], undated
54 48
699 lumped constants in normo, hypo and hyper glycemia [photographs, negative], undated
54 49
700 lumped constants in arterial and venous concentration [photographs, negative], undated
54 50
701 methylglucose sections [photographs, negative], undated
54 51
702 statistical analysis, experiments w/ sq. wave [photographs, negative], undated
54 52
703 rate constants used in calculation of LCGU [photographs, negative], undated
54 53
704 statistical analysis experiments w/ pulse input [photographs, negative], undated
54 54
705 arterial plasma concentration in exp. animals [photographs, negative], undated
54 55
706 LCGU 3K and 4K models [photographs, negative], undated
54 56
707 rate constants -- sq. wave and pulse [photographs, negative], undated
54 57
708 methylglucose sections [photographs, negative], undated
54 58
709 lumped constants w/ sq. wave [photographs, negative], undated
54 59
710 plasma glucose on dowex -- normo, hypo and hyper glycemia [photographs, negative], undated
54 60
711 extraction of metabolites [photographs, negative], undated
54 61
712 recovered DPM [photographs, negative], undated
54 62
713 recovery of sugars from dowex [photographs, negative], undated
54 63
714 correction (Veech) for blood remaining in brain [photographs, negative], undated
54 64
715 r vs. brain glucose concentration [photographs, negative], undated
54 65
716 hexose distribution ratios vs. brain glucose level [photographs, negative], undated
54 66
717 hexose distribution.ratios vs. plasma levels [photographs, negative], undated
54 67
718 non -- acidic, non -- phosph. metabolites [photographs, negative], undated
54 68
719 labeled Non -- acidic and non -- phosphor. metabolites [photographs, negative], undated
54 69
720 phosphorylation coefficient vs. plasma concentration [photographs, negative], undated
54 70
721 elodea cell summary [photographs, negative], undated
54 71
722 methylglucose sections [photographs, negative], undated
54 72
723 elodea cells [photographs, negative], undated
54 73
724 methylglucose mouse [photographs, negative], undated
54 74
725 methylglucose distribution ratio [photographs, negative], undated
54 75
726 steady -- state methylgl. distribution ratio [photographs, negative], undated
54 76
727 total tissue radioactivity [photographs, negative], undated
54 77
728 rate constants estimated from DG and DG-6-P concentration [photographs, negative], undated
54 78
729 rate constants estimated from total tissue radioactivity [photographs, negative], undated
54 79
730 heterogeneous tissue [photographs, negative], undated
54 80
731 rate constant for phosphorylation [photographs, negative], undated
54 81
732 4K rate constants gray matter [photographs, negative], undated
54 82
734 equilibrium MG tissue/ plasma [photographs, negative], undated
54 83
735 time course of DG metabolites [photographs, negative], undated
54 84
736 r vs. Ce [photographs, negative], undated
54 85
737 lumped constant [photographs, negative], undated
54 86
738 brain glucose util. in hyperglycemia [photographs, negative], undated
54 87
739 monkey vs. cortex [photographs, negative], undated
54 88
740 rate constants for various levels of hyperglycemia [photographs, negative], undated
54 89
741 influence of rate constants on integrated pool S.P. [photographs, negative], undated
54 90
744 lumped constant at various levels of hyperglycemia [photographs, negative], undated
54 91
745 effects of hyperinsulinemia [photograph, negative], undated
54 92
748 GHB and temp. vs. time [photographs, negative], undated
54 93
757 [symbol] including equation [photograph], undated
54 94
760 diagram of freely moving rat [photographs, negative], undated
54 95
765 LCGU in sup. collic., cerebellar cortex, med. gen. and int. cap. [negative], undated
54 96
766 LCGU in sup. collic. hypothalamus, int. cap. And rate constants [photographs, negative], undated
54 97
777 autoradiographic film test [photographs, negative], undated
54 98
779 L-thyroxine uptake by brain [photographs, negative], undated
54 99
795 pictorial diagram, protein synth. [photograph], undated
54 100
799 distribution of CO2 in cells [negative], undated
54 101
800 CO2 fixation in cell cultures [photographs], undated
54 102
801 DNA/stairs -- joke [photographs, negative], undated
54 103
811 equation for deoxyglucose methods [photograph], undated
54 104
812 functional anatomy of 2 DG equ. [photographs, negative], undated
54 105
813 tower of matches -- Joke [photographs, negative], undated
54 106
814 nut and bolt -- joke [photographs, negative], undated
54 107
816 equation for Patlak plot [photograph], undated
54 108
817 rates fo hexoses transport [photograph], undated
54 109
818 time courses uptake [photograph], undated
54 110
819 equilibrium of CH3-glucose tissue [photograph], undated
54 111
820 Michaelis-Menten kinetics [photograph], undated
54 112
821 reaction catalyzed by pyruvate carboxylate [photograph], undated
54 113
823 DG-G-P concentration in tissue reflects true average of rates of phosphorylation [photograph], undated
54 114
824 total mixed tissue of two compartments [photograph], undated
54 115
825 effect of glutamine conc. In culture medium [photograph], undated
54 116
826 effect of varying the timing of medium change [photograph], undated
54 117
827 role of individual medium constituents [photograph], undated
54 118
828 glutamine is source of glutamate in culture medium [photograph], undated
54 119
829 destruction of cultures with a brief pulse of medium [photograph], undated
54 120
830 destruction of cultures during medium change (buffer) [photograph], undated
54 121
831 destruction of cell cultures: protection by NMDA [photograph], undated
54 122
832 3-H dopamine uptake vs. concentration of antagonists [photograph], undated
54 123
833 brief exposure to fresh medium (pulse) [photograph], undated
54 124
834 dual pathway for the oxidation of [symbol]-hydrobutyrate [photograph], undated
54 125
835 tech notes: whole-body autoradiographs of mouse for G-6-p-ase activities [photograph], undated
54 126
836 release of dopamine by added ligands [photograph], undated
54 127
837 effects of antagonists on resistance [photograph], undated
54 128
838 percentage uptake of 3-H dopamine vs. concentration of agonists [photograph], undated
54 129
839 effect of glutamine concentration In culture medium [photograph], undated
54 130
840 release of 3-H dopamine from pre-labelled cultures [photograph], undated
54 131
841 reaction catalyzed by the mitochondrial hydroxyacid oxoacid transhydrogenase [photograph], undated
54 132
842 neurotransmitters production cycle [photograph], undated
54 133
843 model of DG method including G-6 p-ase activity [photograph], undated
54 134
844 lumped constant vs. arterial plasma glucose conc. [photograph], undated
54 135
845 DG model including G-6-p-ase activity [photograph], undated
54 136
846 DG model including G-6-p-ase activity, undated
54 137
848 relationships among arterial plasma and brain G. concentration and CMRglc [photograph], undated
54 138
849 apparent dist. Space (whole brain, pont. Gray, cerebral cortex) [photograph], undated
54 139
850 apparent dist. Space (sub. nigra, sens. cortex, int. capsule [photographs, negative], undated
54 140-146
851-857 scientific couns. [not photo], undated
54 147
871 rt. hypoglossal nucleus and rt. nucleus tractus solitarius [photographs], undated
54 148
872 MPTP -- treated and normal [photographs], undated
54 149
873 human -- eyes open and closed [photographs], undated
54 150
875 DG in working monkey spinal cord [photographs], undated
54 151
887 LCGU spinal cord (monkey) [photographs], undated
54 152
889 LCGU spinal cord [photographs], undated
54 153
910 MPTP lab. of cerebral metabolism [photographs], undated
54 154
943 monkey using left arm -- Cerebellum [photographs], undated
54 155
944 monkey using left arm [photographs], undated
54 156
945 paraventricular nucleus [photographs], undated
54 157
946 superior cervical ganglia [photographs], undated
54 158
947 whisker barrel [photographs], undated
54 159
947 whisker barrel CBF paper [photographs, negative], undated
54 160
948 methyl glucose in brain [photographs], undated
54 161
949 monkey using left arm -- Parietal [photographs], undated
54 162
958 pituitary [photographs], undated
54 163
963 monkey using left arm [photographs], undated
54 164
964 striate cortex [photographs], undated
54 165
1001 postnatal change in cerebral blood flow, undated
54 166
1002 phoenoxybenzamine [photograph], undated
54 167
1012 monkey striate cortex (awake vs. sleep) [photographs], undated
54 168
1013 hypoglossal nucleus and tractus solitarius [photographs], undated
54 169
1014 adrenalectomy and dexamethasone [photographs], undated
54 170
1062 monkey ocular dominance columns [photographs], undated
54 171
1126 Joseph Barcroft on oxygen, undated
54 172
1126 quote: oxygen required for work, undated
54 173
1127 methylglucose equilibrium tissue, undated
54 174
1127 pet diagram, undated
54 175
1128 "rate constants" for efflux of DG/phosphorylation, undated
54 176
1129 behavior of DG in heterogeneous tissue, undated
54 177
1130 equation for rate of GU, undated
54 178
1131 behavior of DG in heterogeneous tissue, undated
54 179
1132 heterogeneous model (no loss), undated
54 180
1133 behavior of DG in heterogeneous tissue (no loss), undated
54 181
1134 DG method assumptions, undated
54 182
1135 Y CMR glc. vs. time, undated
54 183
1136 K4 to K3 in simulated mixed tissue, undated
54 184
1137 tissue concentration of DG, DG-6-P and radioactivity estimate with hetero tissue model, undated
54 185
1138 homogeneous tissue: estimated DG, DG-6-P conc., undated
54 186
1139 DG, DG-6-P and radioactivity concentration For simulated heterogeneous tissue, undated
54 187
1140 behavior of DG in heterogeneous tissue, undated
54 188
1141 behavior of DG in homogeneous tissue and loss (4K), undated
54 189
1142 behavior od DG in homogeneous tissue -- 3K, undated
54 190
1143 design for experimental determining of glucose utilization rate, undated
54 191
1144 equation for rate of glucose utilization, undated
54 192
1145 heterogeneous vs. homogeneous -- CMR, undated
54 193
1146 heterogeneity model for DG in tissue, undated
54 194
1147 equation for rate of G.U. (no loss), undated
54 195
1148 emperor's clothes -- quote, undated
54 196
1149 truth / stumble -- quote, undated
54 197
1150 rate constants for various arterial plasma, undated
54 198
1151 model of DG method including G-6-P-ase, undated
54 199
1161 methyl glucose dist. ratio [photographs, negative], undated
54 200
1178 astroglial metabolism, undated
54 201
1179 astroglial metabolism plus potassium, undated
54 202
1180 monkey cortical area [photographs, negative], undated
54 203
1181 MRI + PET in human [photographs], undated
54 204
1185 diagram of AV exchange [photographs, negative], undated
54 205
1186, undated
54 206
1187 on the regulation of the blood supply of the brain, undated
54 207
1189 amino acid incorporation, undated
54 208
1190 regional [symbol] protein synthesis, undated
54 209
1191 Vmax / Km for NADPH, undated
54 210
1192 NADPH production, undated
54 211
1193 kinetic constants for inhibition of GHB-dehydrogenase, undated
54 212
1194 rate of transhydrogenase reaction, undated
54 213
1195 stoichiometry of [symbol]-HB, undated
54 214
1198A steady state ratios of [3H] in tissue pools to plasma, undated
54 215
1200A time courses of plasma, undated
54 216
1201A schematic of the definition of [symbol], undated
54 217
1202 regional values of [symbol] in adult males, undated
54 218
1203A effects of unilateral electrical stimulation, undated
54 219
1204A effects of lt. thiopental anesthesia, undated
54 220
1205A time course of plasma, undated
54 221
1206A denominator of the operational equation, undated
54 222
1207 values of [symbol] and rates of protein in adult male rat, undated
54 223
1208 rate of leucine into protein, undated
54 224
1209 equation of the L-[1-14C] leucine method, undated
54 225
1210 higher brain functions in humans, undated
54 226
1210A, undated
54 227
1211 functional state on protein synthesis, undated
54 228
1212 effects of aging on rates, undated
54 229
1213 values of [symbol] WB in the rat, undated
54 230
1214 effects of unilateral hypoglossal axotomy, undated
54 231
1215 [psi] v. [symbol] in the whole brain, undated
54 232
1216 L-[1-14C] leucine method, undated
54 233
1217 constant C*p for a long experimental interval, undated
54 234
1220 quote from W. Thomson, undated
54 235
1221 substances affecting phosphofructokinase activity, undated
54 236
1222 operational equation of the L-[1-14C] leucine method, undated
54 237
1224 biochemical reaction in vivo, undated
54 238
1225 human myelin basic proteins, undated
54 239
1231, undated
54 240
1232 cerebral blood flow (chat) [photographs, negative], undated
54 241
1233 CBF vs. aging [photographs, negatives], undated
54 242
1234 rCMRglc. vs. tme [photographs, negative], undated
54 243
1235 rate constant vs. end time of last scan [photographs, negative], undated
54 244
1236 K vs. end time of last scan [photographs], undated
55 1
1237 rCMRglc. vs. time [photographs, negative], undated
55 2
1238 gluc. util. vs. midscan time [photographs, negative], undated
55 3
1239 glucose vs. fructose as phosphate donor [photographs, negative], undated
55 4
1240 distribution of 14C in arterial metabolites [photographs, negative], undated
55 5
1242 DG of metabolites levels vs. time of the pulse [photographs, negative], undated
55 6
1243 DPM before and after acid hydrolysis [photographs, negative], undated
55 7
1244 influence of 14C metabolites on G.U. in brain [photographs, negative], undated
55 8
1245 steady state brain -- plasma distribution ratios [photographs, negative], undated
55 9
1247 elution gradient, standards, ethanol extract [photographs, negative], undated
55 10
1249 concentration of DG-6-P in incubation vs. G-1, 6-P-2 concentration [photographs, negative], undated
55 11
1250 lumped constant -- DG vs. brain glucose content [photographs, negative], undated
55 12
1251 gradient elution and ethanol extract, undated
55 13
1252 metabolite concentration vs. incubation time [photographs, negative], undated
55 14
1253 14C --labeled metabolites in ethanol extract [photographs, negative], undated
55 15
1254 concentration of 14C compounds vs. time after DG pulse [photographs, negative], undated
55 16
1256 Huxley quote on mathematics, undated
55 17
1257 profile of acetate elution gradient [photographs, negative], undated
55 18
1259 thiopental anesthesia, undated
55 19
1260 rates of protein synthesis in adult male rat, undated
55 20
1261 L-valine flooding -- protein synthesis, acid soluble pools, undated
55 21
1262 L-valine flooding -- bound a.a. pools, undated
55 22
1263 definition of [symbol], undated
55 23
1264 value of [symbol] in hypoglossal axotomy, undated
55 24
1265 determination of [symbol], undated
55 25
1266 simple operational equation protein synthesis, undated
55 26
1267 operational equation and definitions -- protein synthesis, undated
55 27
1268 denominator of operational equation, undated
55 28
1269 electrical stimulation of sciatic nerve on protein synthesis in spinal cord and DRG, undated
55 29
1270 values of [symbol] in developing rat, undated
55 30
1271 definition of [symbol] in steady state, undated
55 31
1272 flow sheet diagram for protein synthesis experiments, undated
55 32
1273 leucine in tissue pool vs. plasma specific act., undated
55 33
1274 design protein synthesis procedure to simplify equation, undated
55 34
1275 thiopental anesthesia and protein synthesis, undated
55 35
1276 controal and protacaval shunt [photographs, negative], undated
55 36
1277 barbital foci in DG and MG [photographs, negatives], undated
55 37
1278 penicillin focus in DG and MG [photographs, negatives], undated
55 38
1279 developmental time course in kidney [photographs, negatives], undated
55 39
1280 developmental time course in brain [photographs, negatives], undated
55 40
1281 developmental time course in kidney [photographs, negatives], undated
55 41
1282 developmental time course in brain [photographs, negatives], undated
55 42
1283 antibody titration of GHBD in rat brain cytosol [photographs, negatives], undated
55 43
1284 developmental time course in kidney [photographs, negatives], undated
55 44
1285 developmental time course in brain [photographs, negatives], undated
55 45
1286 [photographs, negatives], undated
55 46
1287 effect of whisker stroking on blood flow in whisker-to-barrel pathway[photographs, negatives], undated
55 47
1303 [photographs], undated
55 48
1313 reaction sequence in amino acid incorporation into protein, undated
55 49
1314 reaction sequence in amino acid incorporation into protein, undated
55 50
1315 Lord Kelvin quote, undated
55 51
1316 C. W. Roy and C. S. Sherrington quote, undated
55 52
1317 cartoon by W. Miller, undated
55 53
1325 cat brain [photographs, negative], undated
55 54
1326 [photographs, negative], undated
55 55
1327 homogeneous and heterogeneous tissue model [photographs, negative], undated
55 56
1328 time course of measured radioactivity[photographs, negative], undated
55 57
1329 superior colliculus and lateral geniculate nucleus [photographs, negative], undated
55 58
1330 effect of n-monomethyl-L-arginine on mean arterial blood pressure in rats, undated
55 59
1331 effect of unilaterail whisker stroking on blood flow in unstimulated side of whisker to barrel pathway, undated
55 60
1332 effects of nitric oxide synthase inhibitors on arterial pressure, undated
55 61
1333 effects of nitric oxide synthase inhibitors on increases in cerebral blood flow caused by breathing 5 percent C02, undated
55 62
1334 Distribution of N-methyl-Larginine between blood and brain 10 minutes after I.V. pulse, undated
55 63
1335 effects of systemic infusion of nitric oxide synthase inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stimulation, undated
55 64
1336 effects of intra-cisternal infusion of nitroarginine methy ester on ICBF in whisker-barrel pathway during unilateral whisker stimulation in the unanesthetized rat, undated
55 65
1337 summary, undated
55 66
1338 effects of 5 percent carbon dioxide on physiological variables in rats, undated
55 67
1339 effects of 5 percent C02 on physiological variables in rats following systemic administration of nitric oxide inhibitors, undated
55 68
1340 effects of intracisternal administration of artificial CSF and of nitroarginine on physiological variables in rats, undated
55 69
1341 [photographs, negative], undated
55 70
1342 C. W. Roy and C. S. Sherrington quote, undated
55 71
1346 Kt for brain: plasma glucose transport, undated
55 72
1347 Kt for blood-brain barrier transport of glucose from methylglucose tissue:plasma distribution ratios, undated
55 73
1348 relationship of equilibrium methylglucose tissue:plasma distribution ratio to tissue glucose content in brain, undated
55 74
1349 effects of insulin on local rates of glucose utilization in conscious rat brain, undated
55 75
1350 effects of insulin-induced hypoglycemia on local rates of cerebral glucose utilization in the rat, undated
55 76
1351 brain glucose utilization in hyperglycemia [photographs, negative], undated
55 77
1352 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, undated
55 78
1353 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, undated
55 79
1354 effects of altered arterial blood tensions of respiratory gases on cerebral blood flow and related functions in normal young men, undated
55 80
1355 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-methylarginine or NG-nitroarginine on cerebral blood flow in conscious rats, undated
55 81
1356 brain glucose concentration and lumped constant, undated
55 82
1357 traits of portacaval-shunted rats, undated
55 83
1358 calculation of the rate of glucose utilization in brain, undated
55 84
1359 ammonia levels in control and portacaval-shunted rats, undated
55 85
1360 glucose and glycogen concentrations and brain:plasma distribution ratios for glucose treatment, undated
55 86
1361 steady state brain:plasma distribution ratios for [14C]methylglucose, undated
55 87
1362 glucose and glycogen concentrations and brain:plasma distribution ratios for glucose treatment, undated
55 88
1363 deoxyglucose and glucose, undated
55 89
1364 comparison of levels of ammonia, glucose and glutamine in various portacaval-shunted rats, undated
55 90
1365 glucose levels and lumped constant in portacaval shunted rats, undated
55 91
1366 effects of NOS inhibitor on increases in CBF induced by C02 inhalation in anesthetized ventilated rats, undated
55 92
1367 effects of chronic intraperitoneal administration of NO synthase inhibitor on enzyme activites in brain, undated
55 93
1368 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, undated
55 94
1369 effects of intracisternal administration of NO synthase inhibitor on enzyme activities in brain, undated
55 95
1370 visual pattern discrimination task, undated
55 96
1371 section of the optic tract and corpus callosum 'blinds' the right hemisphere, undated
55 97
1373 theory -- at equilibrium the rates of transport of methylglucose (MG), v*, to and from the brain tissue are equal, undated
55 98
1374 physiological variables before and after topical application of bicuculline and muscimol, undated
55 99
1375 preliminary experiments to evaluate the influence of bicuculline and muscimol on ICMRglc and steady state brain:plasma distribution ratio for [14C]methylglucose, undated
55 100
1376 fig. 1. Ce*/Cp* as function of Ce at Cp = 15.4 mM, undated
55 101
1377 fig. 2. Ce*/Cp* as function of Ce at Cp = 9.5 mM, undated
55 102
1378 fig. 3. Ce*/Cp* as function of Ce at Cp = 6.8 mM, undated
55 103
1379 fig. 4. Ce*/Cp* as function of Ce at Cp = 5.6 mM, undated
55 104
1380 fig. 5. Ce*/Cp* as function of Ce at Cp = 4.5 mM, undated
55 105
1381 fig. 6. Combined results: Ce*/Cp* as function of Ce when Ce is varied mainly by delivery or by the rate of glucose utilization, undated
55 106
1382 fig. 7. Combined theoretical values for Ce as function of Ce*/Cp* and Cp (control of Ce by delivery and ICMRglc), undated
55 107
1383 conclusions, undated
55 108
1384 effects of chronic intraperitoneal administration of nitroarginine methyl ester (50mg/kg twice daily for 4 days) on increases in cerebral blood flow caused by breathing 5 percent C02, undated
55 109
1385 effect of intracisternal administration of nitroarginine methyl ester on nitric oxide synthase in brain, undated
55 110
1386 effect of chronic intraperitoneal administration of nitroarginine methyl ester on nitric oxide synthase in brain, undated
55 111
1387 [14C]iodoantipyrine autoradiographs of brain sections made from z-chloralose/urethane anesthetized rats [photographs, negative], undated
55 112
1388 [14C]deoxyglucose autoradiographs of brain sections from a rat whose vibrissae on the left side were continually stroked [photographs, negative], undated
55 113
1389 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-metylarginine or NG-nitroarginine on arterial blood pC02 and pH, undated
55 114
1390 right-left differences in glucose utilization in primary motor (area 4) and premotor cortex (area 6) in unimanually active monkeys, undated
55 115
1391 right-left percent differences in glucose utilization in primary and secondary somatosensory cortex in unimanually active monkeys, undated
55 116
1392 effects of intravenous administration of NOS inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, undated
55 117
1393 effects of intracisternal administration of nitroarginine ME on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, undated
55 118
1394 assay conditions for brain nitric oxide synthase activity, undated
55 119
1395 effects of intracisternal administration of artificial CSF and of nitroarginine on physiological variables in rats, undated
55 120
1396 effects of nitric oxide synthase inhibitors on increases in cerebral blood flow caused by breathing 5 percent C02, undated
55 121
1397 effect of unilateral whisker stroking on ICBF in whisker-to-barrel pathway (untreated rats), undated
55 122
1398 effects of 5 percent C02 in inspired air on arterial pC02 and pH in normal control rats and in rats administered inhibitors of nitric oxide synthase intravenously, undated
55 123
1399 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-methylarginine or NG-nitroarginine on cerebral blood flow in conscious rats, undated
55 124
1400 [conscious vs. anesthetized glucose utilization [photographs, negative], undated
55 125
1401 relationships among glycolytic and oxidative rates of glucose utilization and ATP turnover, undated
55 126
1402 kinetic basis for obligatory increase in lactate/pyruvate concentrations during increases in oxidative glucose metabolism, undated
55 127
1403 relationship between oxygen and glucose metabolism in normal young adult human brain, undated
55 128
1404 cerebral blood flow and metabolic rate in humans with various disorders affecting mental state, undated
55 129
1406 relationship between cerebral oxygen consumption and glucose utilization in normal young adult man, undated
55 130
1407 energy metabolism per spike in dorsal horn, undated
55 131
1408 ICMRglc per spike in dorsal lumbar cord, undated
55 132
1431astrocytes -- intracellular products, undated
55 133
1432 astrocytes + MSO -- extracellular products, undated
55 134
1433 astrocytes + MSO -- intracellular products, undated
55 135
1434 astrocytes + neurons -- intracellular products, undated
55 136
1435 astrocytes + neurons + MSO -- intracellular products, undated
55 137
1436 astrocytes + neurons + MSO -- extracellular products, undated
55 138
1437 astrocytes + neurons -- extracellular products, undated
55 139
1438 astrocytes -- extracellular products, undated
55 140
1439 [14C]products (DPM), undated
55 141
1440 C02 fixation in primary CNS cultures, undated
55 142
1441 astroglia vs. neurons and astroglia, undated
55 143
1442 MIX-4: AAAnal IC and EC, undated
55 144
1443 K+ concentrations of astroglia and neurons, undated
55 145
1444 the effect of depolarizing agents on C02 fixation in astroglial cells, undated
55 146
1445 the effect of calcium on C02 fixation in astroglial cells, undated
55 147
1446 astroglia, fibroblasts, and neurons, undated
55 148
1447 [14C]deoxyglucose concentration, undated
55 149
1449 autoradiographic calibration [photographs, negatives], undated
55 150
1450 Aristotle quote, undated
55 151
1451 [14C]iodoantyiprine and [14C]deoxyglucose [photographs, negatives], undated
55 152
1452 glucose utilization during unilateral spreading depression in left hemisphere [photographs, negatives], undated
55 153
1453 percent activity newborn rat pup and 20 day rat pup [photographs, negatives], undated
55 154
1454 postnatal age activity [photographs, negatives], undated
55 155
1455 postnatal age activity [photographs, negatives], undated
55 156
1456 postnatal age activity [photographs, negatives], undated
55 157
1457 postnatal age and GHB and GABA concentrations [photographs, negatives], undated
55 158
1458 postnatal age and GHB concentration [photographs, negatives], undated
55 159
1459 postnatal age and activity [photographs, negative], undated
55 160
1460 apomorphine and ICMRglc [photographs, negative], undated
55 161
1461 [14C]iodoantipyrine autoradiographs of brain sections made from z-chloralose/urethane anesthetized rats [photographs, negative], undated
55 162
1462 [photographs, negative], undated
55 163
1463 blood pressure responses to stimulation during electrode placement under anesthesia [photographs, negative], undated
55 164
1464 unilateral and bilateral lesions [photographs, negative], undated
55 165
1465 blood pressure and biphasic stimulation [photographs, negative], undated
55 166
1466 varied blood pressure and biphasic stimulation [photographs, negative], undated
55 167
1467 blood pressure responses [photographs, negative], undated
55 168
1468 unilateral and bilateral lesions [photographs, negative], undated
55 169
1469 [14C]iodoantypyrine and [14C]deoxyglucose [photographs, negative], undated
55 170
1470 [photographs, negative], undated
55 171
1471 [photographs, negative], undated
55 172
1472 postnatal age and ICPSleu [photographs, negative], undated
55 173
1473 postnatal age and ICPSleu [photographs, negative], undated
55 174
1474 postnatal age and CPSleu[photographs, negative], undated
55 175
1475 effects of chronic intraperitoneal nitroarginine on baseline and on increases in blood flow due to unilateral whisker stroking in four stations of the whisker-to-barrel pathway [photographs, negative], undated
55 176
1476 effects of intracisternally infused artificial CSF or nitroarginine on baseline and increases in blood flow due to unilateral stroking of whiskers in four stations of the whisker-to-barrel pathway [photographs, negative], undated
55 177
1477 effects of intravenous nitroarginine on baseline and increases in blood flow in four stations of the whisker-to-barrel pathway due to unilateral stroking of whiskers [photographs, negative], undated
55 178
1478 table 1. Effects of various treatments with nitroarginine on nitric oxide synthase activity in rat brain [photographs, negative], undated
55 179
1481 effects of extracellular potassium ion concentration on phosphorylation of 2-deoxyglucose in cultured neurons and astroglia [title page?], undated
55 180
1482 assay protocol, undated
55 181
1483 standard reaction mixture, undated
55 182
1484 conclusions, undated
55 183
1485 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in astroglia, undated
55 184
1486 cell cultures, undated
55 185
1487 effects of extracellular potassium ion concentration on phosphorylation of [14C]2-deoxyglucose, undated
55 186
1488 effects of dibutyryl cyclic AMP on phosphorylation of [14C]2-deosyglucose in cultured astroglia, undated
55 187
1489 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in astroglia, undated
55 188
1490 effects of veratridine on phosphorylation of [14C]2-deoxyglucose, undated
55 189
1491 effects of extracellular potassium ion concentration on phosphorylation of [14C[-2-deoxyglucose, undated
55 190
1492 table 9. Cerebral blood flow and metabolic rate in humans with various disorders affecting mental state, undated
55 191
1493 table 4. Effects of insulin hypoglycemia on cerebral circulation and metabolism in humans, undated
55 192
1494 table 7. Effects of insulin in normoglycemia, insulin-induced hypoglycemia, and hyperglycemia on local cerebral glucose utilization in the rat, undated
55 193
1495 table 1. Effects of infusions of 2-deoxyglucose (500 mg/kg) on physiological variables, undated
55 194
1496 table 2. The effects of pharmacologic doses of 2-deoxyglucose (500 mg/kg) on local cerebral blood flow (ml/100 g/min), undated
55 195
1497 Ca standards and Ca standard curve [photographs, negative], undated
55 196
1498 Ca concentration gradients [photographs, negative], undated
55 197
1499 Frank and Ernest cartoon (1994), undated
55 198
1500 comic drawing of regions of the brain, undated
55 199
1501 plasma calcium concentrations and clearance of 45Ca from plasma, undated
55 200
1502 total calcium and integrated specific activity of 45Ca in arterial plasma as a function of age, undated
55 201
1503 total brain concentration, brain:plasma distribution ratios, apparent transfer coefficients, and net uptake of calcium into hand-dissected brain regions as a function of age, undated
55 202
1504 gradients of calcium transport in young, middle-aged, and old rats, undated
55 203
1505 rank order of regional uptake of calcium as a function of age, undated
55 204
1506 3-rate-constant (3K), 4-rate-constant (4K) model, and tissue heterogeneity (TH) model [negative], undated
55 205
1507 3K, 4K, and TH models [negative], undated
55 206
1508 3K model [negative], undated
55 207
1509 relationship between accumulated labeled and unlabeled lactate in cerebral cortex during spreading depression, undated
55 208
1510 3K, 4K, and TH models [negative], undated
55 209
1511 specific activities of lactate and glucose as functions of brain glucose level in activated (spreading depression) and control cerebral cortex, undated
55 210
1512 hypothetical reaction mechanism of enzymic NO formation, undated
55 211
1513 conscious and anesthetized glucose utilization, undated
55 212
1514 anonymous humorous quote, undated
55 213
1515 left-right (spreading depression vs. control) differences obtained with labeled deoxyglucose and glucose, undated
55 214
1516 brain:plasma distribution ratios for glucose (Ce/Cp) and [14C] deoxyglucose (Ce*/Cp*) and lambda (i.e., [Ce*/Cp*]/[Ce/Cp]) as functions of brain glucose content in warm- and cold-adapted, active control and hibernating squirrels, undated
55 215
1517 clearance of [14C]DG from squirrel plasma after an intravenous pulse, undated
55 216
1518 brain glucose level as a function of plasma glucose content in warm- and cold-adapted, active controls and hibernating squirrels, undated
55 217
1519 autoradiographic determination of concentrations of total 14C in activated (left) and control (right) cerebral cortex during unilateral KCL-induced activation of CMRglc, undated
55 218
1520 direct chemical assays of concentrations of glucose, [14C]precursor, and 14C-labeled metabolites and calculated rates of glucose utilization in cerebral cortex during KCL-induced activation of CMRglc at 5-7 min after the pulse of [14C]precursor, undated
55 219
1521 levels of glucose and [14C]deoxyglucose in plasma and several brain regions of active and hibernating squirrels at 45 min after a pulse of [14C]deoxyglucose, undated
55 220
1523 brain:plasma distribution ratios for glucose and [14C]deoxyglucose and estimated values for the factor lambda and the lumped constant of the operational equation of the [14C]deoxyglucose method for active and hibernating squirrels, undated
55 221
1524 separation of 14C-labeled metabolites derived from [6-14C]glucose in the control and activated cortex, undated
55 222
1525 physiological variables in active and hibernating ground squirrels, undated
55 223
1526 differences in metabolic rate with the mean rate of barrels A1-3 and E1-3 as reference, undated
55 224
1527 metabolic rates in left (L) and right ( R) barrel cortex [negative], undated
55 225
1528 effect of NO synthase inhibition on autoregulation [photographs, negative], undated
55 226
1529 effects of intravenous infusion of epinephrine on physiological variables and CBF, undated
55 227
1530 effects of glutamate on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55 228
1531 effects of veratridine or monensin on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55 229
1532 effects of veratridine on phosphorylation of [14C]2-deoxyglucose, undated
55 230
1533 effects of veratridine on phosphorylation of [14C]2-deoxyglucose in cultured neurons and astroglia, undated
55 231
1534 effects of dibutyryl cyclic AMP on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55 232
1535 effects of extracellular potassium ion concentration on phosophrylation of [14C]2-deoxyglucose in different types of cultured cells, undated
55 233
1536 effects of chronic treatment with L-NAME on ICMRglc -- part 2, undated
55 234
1537 effects of chronic treatment with L-NAME on ICMRglc -- part 1, undated
55 235
1538 effect of NO synthase inhibition on autoregulation of CBF, undated
55 236
1539 effects of extracellular potassium ion concentration on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55 237
1540 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55 238
1541 effects of chronic treatment with L-NAME on autoregulation of ICBF -- part 1, undated
55 239
1542 effects of chronic treatment with L-NAME on physiological variables, undated
55 240
1543 effects of chronic treatment with L-NAME on physiological variables measured just prior to the infusion of [14C]deoxyglucose, undated
55 241
1544 effects of chronic treatment with L-NAME on autoregulation of ICBF -- part 2, undated
55 242
1545 effects of insulin on physiological variables and CBF in euglycemic rats, undated
55 243
1546 effect of insulin-induced hypoglycemia on cerebral blood flow in conscious rats, undated
55 244
1547 effect of pharmacological doses of deoxyglucose on CBF in conscious rats, undated
55 245
1548 effect of insulin on cerebral blood flow in euglycemic rats, undated
55 246
1549 relationship between CBF and [K+] in insulin-induced htypoglycemia, undated
55 247
1550 relationship between arterial pH and CBF in insulin-induced hypoglycemia, undated
55 248
1551 relationship between plasma lactate and CBF in insulin-induced hypoglycemia, undated
55 249
1552 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, undated
55 250
1553 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, undated
55 251
1554 effects of NOS inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, undated
55 252
1555 arterial plasma valine concentration [photographs, negative], undated
55 253
1556 postnatal age and ICPSleu [photographs, negative], undated
55 254
1557 arterial plasma insulin level, arterial plasma glucose concentration, and arterial plasma valine concentration [photographs, negative], undated
55 255
1558 postnatal age and ICPSleu [photographs, negative], undated
55 256
1559 acute, chronic, and residual cocaine and saline vehicle [photographs, negative], undated
55 257
1560 behavioral scores and days of treatment for chronic vehicle and chronic cocaine [photographs, negative], undated
55 258
1561 postnatal age and CPSleu [photographs, negative], undated
55 259
1562 plasma, extracellular space, and intracellular space [photographs, negative], undated
55 260
1563 lesion of fastigial nucleus and autoregulation of CBF [photographs, negative], undated
55 261
1564 table 1. Physiological variables measured 45 seconds after starting stimulation and 15 seconds prior to the measurement of local cerebral blood flow or local cerebral glucose utilization, undated
55 262
1565 table 2. Effects of electrical stimulation of the left cerebellar fastigial nucleus on local cerebral blood flow, undated
55 263
1566 table 3. Effects of electrical stimulation of the left cerebellar fastigial nucleus on local cerebral glucose utilization, undated
55 264
1567 table 4. Effects of lesions of the cerebellar fastigial nucleus on physiological variables measured just before local cerebral blood flow measurement, undated
55 265
1568 table 5. Effects of left unilateral lesion of the cerebellar fastigial nucleus on local cerebral blood flow, undated
55 266
1569 table 6. Effects of lesions of the cerebellar fastigial nucleus on local cerebral blood flow, undated
55 267
1570 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, undated
56 1
1571 table 3. Effects of increasing extracellular potassium ion concentration on rates of [14C]deoxyglucose phosphorylation in cultured astroglia [photographs, negative], undated
56 2
1572 table 2. Influ4ence of sodium pump activity and neurosecretion on [14C]deoxyglucose uptake in posterior pituitary in vitro, undated
56 3
1573 table 1. Representative values for local cerebral glucose utilization in normal conscious albino rat and monkey, undated
56 4
1574 change in [14C] DG phospohrylation (percentage), undated
56 5
1575 change in [14C] DG phospohrylation (percentage), undated
56 6
1576 effect of pharmacological dose of doexyglucose on cerebral blood flow, undated
56 7
1577 superior colliculus and lateral geniculate nucleus, undated
56 8
1578 veratridine and monensin [photographs, negative], undated
56 9
1579 neuronal, neuronal-astroglial, and astroglial extracellular potassium ion concentration [photographs, negative], undated
56 10
1580 [14C]deoxyglucose-6-phosphate with and without glutamate [photographs, negative], undated
56 11
1581 autoradiographic determination of concentrations of total 14C in activated (left) and control (right) cerebral cortex during unilateral KCL-induced activation of CMRglc, undated
56 12
1582 loss of labeled metabolites of [6-14C]glucose during bilateral spreading cortical depression, undated
56 13
1585 lactate loss from brain during bilateral spreading cortical depression+, undated
56 14
1587 transport of 14C-labeled lactate and inulin in brain during a 10 min interval, undated
56 15
1590 Ce*/Cp* as function of Ce at Cp = 5.6 mM, undated
56 16
1591 combined experimental results: Ce*/Cp* as function of Ce when Ce is varied mainly by delivery or by the rate of glucose utilization, undated
56 17
1592 nucleus accumbens and sensory motor cortex, undated
56 18
1593 caudate-putamen and globus pallidus, undated
56 19
1594 ventral N. thalamus and internal capsule, undated
56 20
1595 average whole brain CBF and insulin-treated euglycemic, undated
56 21
1596 average whole brain CBF with saline + DG and L-NAME + DG, undated
56 22
1597 average whole brain CBF and arterial plasma glucose concentration (mM), undated
56 23
1598 average whole brain CBF and arterial plasma glucose concentration (mM), undated
56 24
1599 table 1. Effects of insulin on physiological variables measured just before CBF measurement, undated
56 25
1600 table 2. Effects of insulin on physiological rats variables in euglycemic rats, undated
56 26
1601 table 3. Effects of pharmacological doses of DG on physiological variables and CBF, undated
56 27
1602 table 4. Effects of chronic treatment with L-NAME on physiological variables in insulin-treated rats, undated
56 28
1603 table 5. Effects of 2-DG and chronic treatment with L-NAME on physiological variables measured just before CBF measurement, undated
56 29
1605 effects of insulin on physiological variables measured just before CBF measurement, undated
56 30
1606 effects of insulin on physiological variables in euglycemic rats, undated
56 31
1607 effects of pharmacological doses of DG on physiological variables and CBF, undated
56 32
1608 effects of 2-DG and chronic treatment with L-NAME on physiological variables measured just before CBF measurement, undated
56 33
1609 effects of chronic treatment with L-NAME on physiological variables in insulin-treated rats, undated
56 34
1610 table 2. Effects of inhibitors of nitric oxide synthase on physiological variables during inhalation of room air or 5 percent C02, undated
56 35
1612 distribution of [U-14C]lactate and its metabolites in brains of anesthetized rats at 10 min after an intracerebral injection, undated
56 36
1613 effect of chronic intraperitoneal administration of nitroarginine on CBF and on increases in CBF produced by 5 percent C02, undated
56 37
1614 conclusions, undated
56 38
1619 newborn astroglia, undated
56 39
1620 extracellular and intracellular astroglia and neurons, undated
56 40
1640 effects of intravenous infusions of epiephrine on cerebral glucose utilization, undated
56 41
1641 effects of intravenous infusions of epinephrine on cerebral blood flow, undated
56 42
1642 effects of caffeine on CBF enhancement by insulin-induced hypoglycemia, undated
56 43
1643 effects of glibenclamide on CBF enhancement by insulin-induced hypoglycemia, undated
56 44
1644 CBF as a function of plasma glucose concentration, undated
56 45
1645 CBF as a function of plasma glucose concentration, undated
56 46
1646 CBF as a function of plasma glucose concentration, undated
56 47
1647 CBF as a function of arterial glucose concentration, undated
56 48
1648 CBF vs plasma glucose concentration in insulin-treated rats without and after pretreatment with nitroarginine, undated
56 49
1649 effect of insulin on CBF in euglycemic rats, undated
56 50
1650 arterial plasma glucose and catecholamines induced by glucoprivation due to insulin administration or pharmacological doses of deoxyglucose, undated
56 51
1651 effects of acute and chronic nitroarginine pretreatment on CBF enhancement by pharmacological doses of 2-deoxyglucose, undated
56 52
1652 effects of acute and chronic nitroarginine pretreatment on CBF enhancement by insulin-induced hypogylcemia, undated
56 53
1653 [14C]deoxyglucose-6-phosphate and glutamate [photographs], undated
56 54
1654 effects of insulin on physiological variables in euglycemic rats, undated
56 55
1655 diffusion-equilibrium blood flow model, undated
56 56
1657 effects of caffeine on local cerebral blood flow during functional activation of whisker-barrel pathway, undated
56 57
1658 calculated and measured methylglucose distribution ratio, undated
56 58
1659 calculated and measured brain glucose content, undated
56 59
1660 control of brain glucose level mainly by supply (constant demand), undated
56 60
1661 control of brain glucose level mainly by demand (constant supply), undated
56 61
1662 table 2. Influences of bicuculline and muscimol on rate of glucose utilization and methylglucose brain:plasma distribution ratio, undated
56 62
1663 table 1. Physiological variables in animals studied with topical applications of bicuculline or muscimol, undated
56 63
1664 diffusion-equilibrium blood flow model, undated
56 64
1665 average whole brain CBF and glibenclamide, undated
56 65
1666 average whole brain CBF and caffeine, undated
56 66
1667 concluding remarks, undated
56 67
1668 cerebral circulation and metabolism during deep sleep, undated
56 68
1669 local cerebral glucose utilization in non-rapid eye movement sleep in monkeys, undated
56 69
1670 cerebral circulation and metabolism during sleep and mental 'work', undated
56 70
1671 cerebral circulation and metabolism in schizophrenia and LSD-induced psychotomimetic state, undated
56 71
1672, undated
56 72
1673 rates of leucine incorporation and weighted percentage time in deep sleep, undated
56 73
1674 effects of catecholamines on cerebral circulation and metabolism, undated
56 74
1675 protein synthesis in deep sleep, undated
56 75
1676 table II. Cerebral nutritional insufficiency and mental state, undated
56 76
1677 table IV. Cerebral circulation and metabolism in normal aging, arteriosclerosis and chronic brain syndrome, undated
56 77
1679 hyperpolarization, relaxation, and vasodilation, undated
56 78
1680 table 2. Relationship between oxygen and glucose metabolism in normal young adult human brain, undated
56 79
1681 table 1. Substances utilized or produced by normal young adult human brain, undated
56 80
1682 relationships among glycotic and oxidative rates of glucose utilization and ATP turnover in normal conscious human brain, undated
56 81
1683 energy metabolism per spike, undated
56 82
1684 energy metabolism per Hz, undated
56 83
1686 table II Substrates of cerebral energy metabolism in human adults during prolonged starvation, undated
56 84
1687 molecular layer of hippocampus, undated
56 85
1688 cerebral blood flow, undated
56 86
1689 table 2. Metabolite levels in cerebral cortex before, during and following sensory stimulation, undated
56 87
1690 table 1. Physiological variables and arteriovenous differences just prior to in situ freezing, undated
56 88
1691 spinal trigeminal nucleus, principal sensory trigeminal nucleus, VPM thalamic nucleus, and somatosensory cortex, barrel field [negatives], undated
56 89
1692 cerebral blood flow [negatives], undated
56 90
1693 table 1. Effects of scopolamine on physiological variables, undated
56 91
1694 C. S. Roy and C. S. Sherrington quote, undated
56 92
1695 C. S. Roy and C. S. Sherrington quote, undated
56 93
1696 average whole brain CBF and caffeine and glibenclamide, undated
56 94
1697 average whole brain CBF and arterial plasma glucose concentration, undated
56 95
1698 table 1. Effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions, and pharmacologic doses of 2-deoxyglucose on blood constituents and global cerebral blood flow, undated
56 96
1699 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, and somatosensory cortex barrel field, undated
56 97
1700 cerebellar white matter, caudate-putamen, primary motor cortex, and accumbens nucleus core, undated
56 98
1701 table 2. Effects of insulin-induced bypoglycemia and pharmacological doses of 2-doexyglucose on adenosine, inosine, and hypoaxanthine levels in conscious rat brain, undated
56 99
1702 weighted average whole brain blood flow and epinephrine, undated
56 100
1703 table 1. Physiological variables and arteriovenous differences just prior to in situ freezing, undated
56 101
1704 resources -- Louis Sokoloff, M.D. -- Laboratory of Cerebral Metabolism, undated
56 102
1705 table 2. Metabolite levels in cerebral cortex before, during and following sensory stimulation, undated
56 103
1707 resources -- Louis Sokoloff, M.D. -- Laboratory of Cerebral Metabolism, undated
56 104
1708 compartmental models that do not meet the conditions for application of spectral analysis to total tissue activity, undated
56 105
1709 compartmental models that satisfy the conditions for application of spectral analysis to total tissue activity, undated
56 106
1710 compartmental systems formed by removing a link from a strongly connected noncyclic system, undated
56 107
1711 construction of the sign-symmetric completion of a compartmental system, undated
56 108
1712 strongly connected noncyclic compartmental systems, undated
56 109
1713 residual intracellular 2-[14C]DG-6-P after extended incubation, undated
56 110
1714 [14C] glucose standard, zero time, 5 minute incubation, 10 minute incubation, and 15 minute incubation, undated
56 111
1715 phosphorylation reaction and phosphatase activity, undated
56 112
1716 time course of 3H/14C ratio during incubation of astroglia with [2-3H]Glucose and [U-14C]glucose, undated
56 113
1717 residual intracellular 2-[14C]DG-6-P after extended incubation, undated
56 114
1718 active and hibernating effluent volumes, undated
56 115
1719 ribosomes and [3H]-leucine incorporation, undated
56 116
1720 active and hibernating [3H]-leucine incorporation, undated
56 117
1721 molecular mechanisms in physiological regulation of cerebral blod flow and metabolism [title page?], undated
56 118
1722 background, undated
56 119
1723 effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions, and opharmacologic doses of 2-deoxyglucose on systemic physiological variables that might influence cerebral blood flow, undated
56 120
1724 effects of insulin-induced hypoglycemia, insulin administratio nunder euglycemic conditions and pharmacologic doses of 2-deoxyglucose on blood constituents and global cerebral blood flow, undated
56 121
1725 recent and current research, undated
56 122
1726 conclusions, undated
56 123
1728 active and hibernating [3H]-leucine incorporation, undated
56 124
1729 intracellular 14C DPM and 3H DPM distances from origin, undated
56 125
1730 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56 126
1731 intracellular 14C DPM distances from origin, undated
56 127
1732 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56 128
1733 table3. Relationship between cerebral oxygen consumption and glucose utilization in a normal young adult man, undated
56 129
1734 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, undated
56 130
1735 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, undated
56 131
1736 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56 132
1737 intracellular 14C DPM distances from origin, undated
56 133
1738 extracellular 14C DPM distances from origin, undated
56 134
1739 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56 135
1740 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, undated
56 136
1741 intracellular 14C DPM and 3H DPM distances from origin, undated
56 137
1742 table 1. Physiological variables immediately before measurement of cerebral blood flow, undated
56 138
1743 table 2. Effects of caffeine on CBF during sitmulation of vibrissae on left side of face in structures outside whisker-barrel pathway, undated
56 139
1744 table 3. Effects of caffeine on activation of local cerebral glucose utilization (ICMRglc) by vibrissal stimulation in whisker-to-barrel cortex sensory pathway, undated
56 140
1745 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, undated
56 141
1746 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, undated
56 142
1747 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, undated
56 143
1748 intracellular 14C DPM and 3H DPM distances from origin, undated
56 144
1749 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56 145-148
1750-1753 extracellular 14C DPM distances from origin, undated
56 149
1754 time courses of intracellular and extracellular 14C contents -- standard assay conditions, undated
56 150
1755 extracellular 14C DPM distances from origin, undated
56 151
1756 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, undated
56 152
1757 table 1. Physiological variables immediately before measurement of cerebral blood flow, undated
56 153
1758 diffusion-equilibrium blood flow model, undated
56 154
1759 table 1. The effect of extracellular potassium concentration on lactate formation in astroglial cells in culture, undated
56 155
1760 table 2. The effect of extracellular potassium on C02 fixation and on lactate formation in astroglial cells in culture, undated
56 156
1761 table 3. Products formed by astroglial cells incubated with 14C-labeled bicarbonate: the effect of increased extracellular potassium, undated
56 157
1762 table 4. Glucose utilization in cells in culture, undated
56 158
1763 table 5. The effect of L-lactate on the oxidation of D-Glucose (2.5mM) to C02, undated
56 159
1764 table 6. The effect of D-Glucose on the oxidation of L-lactate (2mM) to C02, undated
56 160
1765 Ce*/Cp* as function of Ce at Cp = 6.8 mM, undated
56 161
1766 Ce/Cp* as function of Ce at Cp = 4.5 mM, undated
56 162
1767 frequency of stimulation of glucose utilization [photographs, negative], undated
56 163
1768 functioal plasticity in barrel cortex after depression, undated
56 164
1769 combined theoretical values for Ce as function of Ce*/Cp* and Cp (control of Ce by delivery and CMRglc), undated
56 165
1770 selective trapping of 45Ca during metabolic activation [photograph], undated
56 166
1771 selective trapping of 45Ca during metabolic activation [photograph], undated
56 167
1772 effect of unilateral visual stimulation on glucose utilization, effect of visual stimulation on the increase in glucose utilization in superior colliculus, relative increase in glucose utilization in stimulated superior colliculus, undated
56 168
1773 table 1. Influence of sodium pump activity and neurosecretion on [14C]deoxyglucose uptake in posterior pituitary in vitro, undated
56 169
1774 diagram of veins and sinuses of the human brain [photograph], undated
60
071053 -- autoradiographs, undated
60
071753A -- RA9 [photograph, negative], undated
60
071753A -- 10 [photograph, negative], undated
60
071753A -- 17 [photograph, negative], undated
60
071753A -- 26 [photograph, negative], undated
60
071753A -- RA27 [photograph, negative], undated
60
071753A -- RA29 [photograph, negative], undated
60
071753B [photographs, negatives], undated
60
072453A #1 [photograph, negative], undated
60
072453A #2 [photograph, negative], undated
60
072453A #3 [photograph, negative], undated
60
072453A #5 [photograph, negative], undated
60
072453A [photograph, negative], undated
60
072453A [photograph, negative], undated
60
072453A [photograph, negative], undated
60
072453B -- no densitometry [photograph, negative], undated
60
072453B #4 RA6 [negative], undated
60
073053A #1 [photograph, negative], undated
60
073053A #2 [photograph, negative], undated
60
073053A #3 [photograph, negative], undated
60
073053A #5 [photograph, negative], undated
60
073053A #6 [photograph, negative], undated
60
073053A #7 [photograph, negative], undated
60
073053A #8 [photograph, negative], undated
60
073053B -- 9 [photograph, negative], undated
60
073053B -- 10 [photograph, negative], undated
60
073053B -- 11 [photograph, negative], undated
60
073053B -- 12 [photograph, negative], undated
60
073053B -- 13 [photograph, negative], undated
60
073053B -- 14 [photograph, negative], undated
60
073053B -- 15 [photograph, negative], undated
60
073053B -- 16 [photograph, negative], undated
60
080653A -- AR17 [photograph, negative], undated
60
080653A -- AR18 [photograph, negative], undated
60
080653A -- AR19 [photograph, negative], undated
60
080653A -- AR20 [photograph, negative], undated
60
080653A -- AR21 [photograph, negative], undated
60
080653A -- AR22 [photograph, negative], undated
60
080653A -- AR23 [photograph, negative], undated
60
080653A -- AR24 [photograph, negative], undated
60
080653A -- AR25 [photograph, negative], undated
60
080653A -- AR26 [photograph, negative], undated
60
080653A -- AR27 [negative], undated
60
080653A -- AR28 [photograph, negative], undated
60
080653A -- AR29 [photograph, negative], undated
60
080653B [photographs, negatives], undated
60
081353 [negatives], undated
60
5613001 -- cat 40s-10 [negative], undated
60
5613002 -- 3 C02-10 [negative], undated
60
5613003 -- 5 C02-10 [negative], undated
60
5613004 -- 3 02-10 [negative], undated
60
5613005 -- 2 C02-10 [negative], undated
60
5613006 -- CT6 C02-10 [negative], undated
60
5613007 -- 6 C02-10; 4 02-10 [negative], undated
60
5613008 -- 4 C0-10 [negative], undated
60
564102 [negative], undated
60
564103 [negative], undated
60
564104 [negative], undated
60
564105 [negative], undated
60
564106 [negative], undated
60
564101 [negative], undated
 
Cat, 1953-1957, undated
60
5612701 -- cat 5 W2-5 [negative], undated
60
5612702 -- cat SCL 2 [negative], undated
60
5612703 -- cat SCL 4 [negative], undated
60
5612704 -- cat 102-10 [negative], undated
60
5612705 -- cat SCL 8 [negative], undated
60
5612706 -- cat SCL 15 [negative], undated
60
5612707 -- cat 202-10 [negative], undated
60
5612708 -- cat 1 C02-5 [negative], undated
60
5612709 -- cat SCL 6 [negative], undated
60
5612710 -- cat SCL 3 [negative], undated
60
5612711 -- cat SCL 4 [negative], undated
60
5612712 -- cat 1 C02-10 [negative], undated
60
5612713 -- control cat 2 02-10, 1 C02-10 [negative], undated
60
5612714 -- cat 4 C02-5 [negative], undated
60
5612715 -- cat 5 SCL [negative], undated
60
5612716 -- cat 2 C02-5 [negative], undated
60
5612717 -- cat 14 SCL [negative], undated
60
5612718 -- cat 3 C02-5 [negative], undated
60
5612719 -- cat 13 SCL [negative], undated
60
5612720 -- cat SCL 12 [negative], undated
60
5612721 -- cat SCL 1 [negative], undated
60
5612722 -- cat 6 C02-5 [negative], undated
60
Cat no. 1 -- 12/3 [negatives], 1953
60
Cat no. 2 [negatives], undated
60
Cat no. 3 -- 12/17 [negatives], 1953
60
Cat no. 4 -- 2/17 [negatives], 1953
60
Cat no. 5 -- 1/7 [negatives], 1954
60
Cat no. 6 -- 1/7 [negatives], 1954
60
Cat no. 7 -- 1/14 [negatives], 1954
60
Cat no. 7 and 8 -- heart and kidney [negatives], undated
60
Cat no. 8 -- 1/14 [negatives], 1954
60
Cat no. 9 -- 2/4 [negatives], 1954
60
Cat no. 10 -- 2/4 [negatives], 1954
60
Cat no. 11 -- 2/11 [negatives], 1954
60
Cat no. 12 -- 2/11 [negatives], 1954
60
Cat no. 13 -- saturation -- 2/12/54 (#2 and 22 taken 5/21/57) [negatives], 1954-1957
60
Cat no. 14 -- saturation -- 2/12/54 (#9 taken 5/21/57) [negatives], 1954-1957
60
Cat no. 15 -- 2/25 -- cochlea destroyed [negatives], 1954
60
Cat no. 16 -- 2/25 -- cochlea destroyed [negatives], 1954
60
Cat no. 17 -- 3/4 -- cochlea destroyed [negatives], 1954
60
Cat no. 18 -- 3/4 -- cochlea destroyed [negatives], 1954
60
Cat no. 19 -- 5/20 [negatives], 1954
60
Cat no. 20 -- 5/20 [negatives], 1954
60
Cat no. 21 -- 5/29 -- lambda [negatives], 1954
60
Cat no. 23 -- 6/3 [negatives], 1954
60
Cat no. 23 -- 6/3 -- lambda [negatives], 1954
60
Cat no. 24 -- 6/3 (#11 and 16 in slides) [negatives], 1954
60
Cat no. 25 -- repeat (air exposure) -- 6/9 [negatives], 1954
60
Cat no. 26 -- 6/9 [negatives], 1954
60
Cat no. 26 -- 6/9 -- reput [negatives], 1954
60
Cat no. 27 -- 6/17 [negatives], 1954
60
Cat no. 28 -- 6/17 [negatives], 1954
60
Cat no. 29 -- 6/24 [negatives], 1954
60
Cat no. 30 -- 6/24 [negatives], 1954
60
Cat no. 31 -- 7/1 -- films 41, 45, 49 taken for England [negatives], 1954
60
Cat no. 32 -- 7/1 [negatives], 1954
60
Cat no. 33 -- 7/8 [negatives], 1954
60
Cat no. 34 -- 7/18 -- for illustrations #17 and 20 in slides [negatives], 1954
60
Cat no. 35 -- 6/9 -- lampda [negatives], 1954
60
Cat no. 35 -- 7/15 [negatives], 1954
60
Cat no. 36 -- 7/15/54 (#45 to England) [negatives], 1954
58
Cat 1 02 10 [negatives], undated
58
Cat 2 02-10 [negatives], undated
58
Cat 2 02-10 control for 2 02-10, 1C02-10 [negatives], undated
58
Cat 3 02-10 -- fig. 1A [negatives], undated
58
Cat 4 02-10 [negatives], undated
58
Control for Cat 4 02-10 and 6 C02-10 [negatives], undated
58
Cat 5 02-10 -- control 10 C02 5 [negatives], undated
58
Cat 6 02-10 [negatives], undated
58
Cat 7 02-10 [negatives], undated
58
Cat 1 02-100 -- May 14 [negatives], 1957
58
Cat 2 02-100 [negatives], undated
58
Cat 3 02-100 [negatives], undated
58
Cat 5 02-100 [negatives], undated
58
Cat 6 02-100 [negatives], undated
58
Cat 7 02-100 (control) [negatives], undated
58
Cat 8 02-100 [negatives], undated
58
Cat 9 02-100 [negatives], undated
58
Cat 10 02-100 [negatives], undated
58
Cat 1 C02-5 -- used #20 for slide for fed. meet -- 4/15 [negatives], 1957
58
Cat 2 C02-5 -- 9/26 [negatives], 1956
58
Cat 3 C02-5 [negatives], undated
58
Cat 4 C02-5 [negatives], undated
58
Cat 5 C02-5 [negatives], undated
58
Cat 5 C02-5 -- film too dark, other film of this cat more acceptable [negatives], undated
58
Cat 6 C02-5 [negatives], undated
58
Cat 7 C02-5 [negatives], undated
58
Cat 8 C02-5 [negatives], undated
58
Cat 9 C02-5 [negatives], undated
58
Cat 10 C02-5 [negatives], undated
58
Cat 11 C02-5 [negatives], undated
58
Cat 12 C02-5 [negatives], undated
58
Cat 13 C02-5 [negatives], undated
58
Cat 14 C02-5 [negatives], undated
58
Cat 15 C02-5 [negatives], undated
58
Cat 16 C02-5 [negatives], undated
58
Cat 17 C02-5 -- May 14 [negatives], 1957
58
Cat 1 C02-10 -- film 27 used for England, used film 28 for slide fed meet. 4/15 [negatives], 1957
58
Cat 2 C02-10 -- make darkest -- fig 1C [negatives], undated
58
Cat 3 C02-10 [negatives], undated
58
Cat 4 C02-10 [negatives], undated
58
Cat 5 C02-10 -- fig 1B [negatives], undated
60
Cat 1 SCL -- 5/8 -- unstimulated control (#8 to England) [negatives], 1956
60
Cat 2 SCL -- 5/8 -- 5' retinal stimulation (#19 and 21 to England) [negatives], 1956
60
Cat 3 SCL -- 5/11 -- stimulated cat [negatives], 1956
60
Cat 4 SCL -- 5/11 -- unstimulated cat (#20 to England) [negatives], 1956
60
Cat 5 SCL -- 5/24 -- stimulated [negatives], 1956
60
Cat 6 SCL -- 5/24 [negatives], 1956
60
Cat 7 SCL -- 7/3 -- control [negatives], 1956
60
Cat 8 SCL -- 7/3 -- 5' retinal stimulation [negatives], 1956
60
Cat 9 SCL -- 7/26 -- stimulated 10' [negatives], 1956
60
Cat 11 SCL -- 10 minutes stimulation -- 7/30 [negatives], 1956
60
Cat 12 SCL -- 5' retinal stimulation -- 9/11 [negatives], 1956
60
Cat 13 SCL -- 9/11 -- control for 5 stimulation (note: film #24 not used) [negatives], 1956
58
Cat 1-SCLN (too dark to use) [negatives], undated
58
Cat 3-SCLN [negatives], undated
59
Cat 1ON -- 1/26 -- stimulated optic nerve [negatives], 1956
59
Cat 2ON -- 1/26 -- optic nerve crushed [negatives], 1956
59
Cat 1P -- 12/16/54 -- pentothal -- #8 to slide [negatives], 1954
59
Cat 2 -- 12/23 -- pentothal [negatives], 1957
59
Cat 3P -- 12/30/54 -- cat 3 pentothal [negatives], 1954
59
Cat 4P -- 12/30/54 -- pentothal [negatives], 1954
59
Cat 5P -- 1/6/55 -- pentothal cat [negatives], 1955
59
Cat 6P -- 1/6/55 -- pentothal cat [negatives], 1955
59
Cat 7P -- 1/13/55 -- pentothal [negatives], 1955
59
Cat 8P -- 1/13/55 -- pentothal [negatives], 1955
59
Cat 11P -- 2/4/55 -- pentothal [negatives], 1955
59
Cat 12P -- 2/4/55 -- pentothal [negatives], 1955
59
Cat 13P -- 2/7/55 [negatives], 1955
59
Cat 14P -- 2/17/55 [negatives], 1955
59
Cat 1PS -- 5/11/55 -- film series "a" [negatives], 1955
59
Cat 1PS -- 5/11/55 [negatives], 1955
59
Cat 2PS -- 5/11/55 -- film series "a" [negatives], 1955
59
Cat 2PS -- 5/11/55 [negatives], 1955
59
Cat 3PS -- 5/12/55 [negatives], 1955
59
Cat 4PS -- 5/12/55 [negatives], 1955
59
Cat 5PS -- 5/13/55 -- negative #3 and 6 -- make into slides [negatives], 1955
59
Cat 1V -- 10/20/55 (films 23 and 24 out of order) [negatives], 1955
59
Cat 2V -- 10/20/55 -- (films 21 and 22 were out of order) [negatives], 1955
59
Cat 3V -- 10/24/55 [negatives], 1955
59
Cat 4V -- 10/24/55 [negatives], 1955
59
Cat 5V -- 10/26/55 [negatives], 1955
59
Cat 5V -- 10/26/55 [negatives], 1955
59
Cat 6V -- 10/26/55 -- lost tissue section [negatives], 1955
59
Cat 7V -- 11/16/55 -- films too light [negatives], 1955
59
Cat 7V -- films "A" repeat -- 11/16/55 [negatives], 1955
59
Cat 8V -- 11/16/55 [negatives], 1955
59
Cat 9V -- 11/17/55 [negatives], 1955
59
Cat 10V -- 11/17/55 [negatives], 1955
59
Cat 11V -- 11/23/55 [negatives], 1955
59
Cat 12V -- 11/23/55 [negatives], 1955
59
Cat 1VP -- 1/19 -- film 18 not used [negatives], 1956
59
Cat 2VP -- 1/19 [negatives], 1956
59
Cat 3VP -- 1/20 -- not stimulated visually [negatives], 1956
59
Cat 3VP and Cat 4VP -- 1/20 -- visually stimulated [negatives], 1956
59
Cat L1(a) -- 7/7/55 [negatives], 1955
59
Cat L1 -- 7/7/55 [negatives], 1955
59
Cat L2 -- 7/7/55 [negatives], 1955
59
Cat L4 -- 7/16/55 [negatives], 1955
59
Cat L5 -- 7/21/55 [negatives], 1955
59
Cat L6 -- "Lou" [negatives], undated
59
Cat L7 -- 7/28/55 [negatives], 1955
59
Cat L8 -- 7/28/55 [negatives], 1955
 
P, undated
56 170
P 107 diazepam vs. control [photographs], undated
56 171
P 108 D and M lesion vs. control [photograph], undated
56 172
P 109 morphine vs. control [photographs], undated
56 173
P 110 LBH lesion vs. control [photographs], undated
56 174
P 163 arumd (Kennedy) [photographs], undated
56 175
P 192 thiopental rat [photographs], undated
 
SM, undated
56 176
SM-3 [photographs], undated
56 177
SM-6 (both eyes patched) [photographs, negatives], undated
56 178
SM-12 [photographs], undated
56 179
SM-13 left eye enucleation [photograph], undated
56 180
SM-14 [photograph], undated
56 181
SM-21, undated
56 182
SM-21 rt. eye enucleation [photographs, negative], undated
56 183
SM-23 control [photographs, negatives], undated
56 184
SM-25 [photographs], undated
56 185
SM-26 eye patched [photographs, negative], undated
56 186
SM-27 [photographs, negative], undated
56 187
SM-28 long term monocular occlusion [photographs, negative], undated
56 188
SM-29 [photographs, negative], undated
56 189
SM-33 [photographs, negative], undated
56 190
SMII -- both eyes open before rotatory screen [photographs, negatives], undated
 
Unnumbered, 1954-1988
56 191
Unidentified negatives [photographs, negative], undated
60
[unidentified] [negatives], undated
60
[unidentified] [negatives], undated
56 192
A/V DG plasma concentration in cat [photographs], undated
56 193
ARC 146A Stds. (OMI film), 1985-1986
56 194
Blood flow in anesthetized rats [photographs, negatives], undated
136 22
Buhda Films, undated
56 195
CBF and CMR 02 [photographs, negatives], undated
56 196
CBF and CMR 02 [photographs, negatives], undated
56 197
Circulatory system of the human head [photographs, negative], undated
56 198
Cocaine [photograph], undated
56 199
Crop [photographs, negative], undated
60
Densitometric calibration control -- 6/18 -- 9 stds [negative], 1954
56 200
Derivation of Patlak plot [photographs], undated
56 201
Effect of morphine on glucose utilization [photographs], undated
56 202
Effective rate "constant" vs. time [photographs, negative], undated
56 203
Electrophoretic patterns of purified HMBP's [photographs, negatives], undated
56 204
Exposure [negative], 1988
58
1st attempt to judge if the krypton 85 diffuses out of std with sawing -- too dark, probably not [negatives], undated
58
2nd attempt to judge if Kr85 diffuses from head with sawing -- not as can be determined [negatives], undated
56 205
Human central anterior circulation [photographs, negative], undated
56 206
Hypophysis [photographs], undated
56 207
Hypothalamus (insulin effect on LGU) [photographs, slide], undated
56 208
Joke: "May be on to something. . ." [negative], undated
56 209
LCBF [photographs, negatives], 1971
56 210
LCBF in mice [photographs, negatives], undated
56 211
LCGU in sup. collic. and lateral geniculate nucleus [photographs, negative], undated
56 212
Lateral surface of the macaque brain [negatives], undated
56 213
Leg blood flow metabolism [photographs, negatives], undated
56 214
Locus coeruleus [photographs], undated
56 215
MEG of rat L + R enucleation -- sup. col. only -- test photos [negatives], undated
60
Materials for slides, undated
56 216
Methods fig. [photographs, negatives], undated
56 217
Misc. [negatives], undated
56 218
Model and operational equation for equilibrium method for the determination of local cerebral blood flow, undated
56 219
Monkey not working [photographs], undated
56 220
Monkey put. in Parkinsonism [photographs, negative], undated
56 221
Monkey using lt. arm suppl. motor ctx. [photographs], undated
56 222
Motor cortex [photographs, negative], undated
56 223
Moving lt. arm and inactive [photographs, negative], undated
59
Name -- Seymour [negatives], undated
59
Name -- Lou [negatives], undated
59
Name -- Bill [negatives], undated
59
Name -- Bud [negatives], undated
59
Name -- Walt [negatives], undated
59
Name -- Darob [negatives], undated
59
Name -- Mary [negatives], undated
59
Name -- Bob [negatives], undated
56 224
Newborn 101, long term patching, 1976-1977
56 225
Newborn (NBM 2) eye patched [photographs, negative], undated
56 226
Newborn (NBM 5) control [photographs, negative], undated
56 227
Newborn (NBM-6) control [photographs, negative], undated
56 228
Newborn (NBM-I) control [photographs, negative], undated
56 229
Newborn puppies. antipyrine -- blood flow [photographs], undated
56 230
Nose -- photos [photographs], undated
57 1
Operational equation [photographs], undated
57 2
Parkinsonian syndrome [photographs, negatives], undated
57 3
Percentage dephosphorylation of [14C] DG-6-P at time F [photographs, negatives], undated
57 4
Phosphate [photographs, negative], undated
57 5
Postmortem changes in DG and metabolites [photographs, negative], undated
57 6
Rat -- normal controls -- LCGU [photographs], undated
57 7
Rat auditory structures LCGO, undated
57 8
Rat visual structure LCGU, enucleation [photograph], undated
57 9
Sciatic n. stimu. and DRG [photographs], undated
57 10
Subfornical organ [photograph, slide], undated
57 11
Subfornical organ vs. saline, A 11 and saralasin A11 [photograph], undated
57 12
Sugar [photographs], undated
57 13
T 86 changes in metabolic activity following stimu. of the ventral, undated
136 23
Tattoo Films, undated
57 14
Thiomin section -- rat spinal cord [photographs], undated
57 15
Windy -- photos [photographs, negative], undated
57 16
Wortz geometric design [photographs], undated
58
X-sympathetic stim. [negatives], undated
 
Autoradiographs, 1970-2002
61
Standards C14, Cold Brain, Puppy Lambda, Equilibrium study [48 autoradiographs], 1970-1985
61
Cat-1 and Cat-3 [19 autoradiographs], 1971
61
CBF Cat-1 through CBF Cat-6 [38 autoradiographs], 1971
61
EC-1 [1 autoradiograph], 1971
61
Rat X-2 [1 autoradiograph, 1971
61
C-1 through C-2 [3 autoradiographs], 1973
61
DG-101 through DG-122; HR-201 [29 autoradiographs], 1973, 1976
61
DG-201A through DG-216A -- experiment documentation, 1973
61
DG-201A through DG-216A [19 autoradiographs], 1973
61
DGH3-test and DGH3-1 [4 autoradiographs], 1973
61
MG-5-6, 8-9, 12, 14-16 [8 autoradiographs], 1973
61
MG-101 through MG-114 [14 autoradiographs], 1973
61
MG-1-4, 7, 10, 13, 17, 18; Methyl glucose 10 minutes [10 autoradiographs], 1973, 1977
61
SC1 and SC1A [23 autoradiographs], 1973
61
SM-2 [stimulated squirrel monkey] [23 autoradiographs], 1973
61
SM-2A [stimulated squirrel monkey] [10 autoradiographs], 1973
61
SM-3 [stimulated rhesus monkey] [11 autoradiographs], 1973
61
SM-4A [stimulated monkey] [18 autoradiographs], 1973
62
SR-1 through SR-5 [visual experiment]; SSR-1 through SSR-4 [sciatic nerve stimuli]; AUD-test and 2 through AUD-4 [auditory experiment] [24 autoradiographs], 1973-1974
62
ARF-1 through ARF-16 [CBF antiyprene] [18 autoradiographs], 1974
62
Monkey and rat intestines [1 radiograph], 1974
62
SM-3A [stimulated rhesus monkey] [19 autoradiographs], 1974
62
SM-5 [stimulated rhesus monkey] [16 autoradiographs], 1974
62
SM-6 [stimulated rhesus monkey] -- experiment documentation, 1974
62
SM-6 [stimulated rhesus monkey] [28 autoradiographs], 1974
62
SM-7 [stimulated monkey] [5 autoradiographs], 1974
62
SM-8A [stimulated rhesus monkey] [13 autoradiographs], 1974
62
SM-9A [stimulated rhesus monkey] [11 autoradiographs], 1974
62
SM-10 [stimulated monkey] [21 autoradiographs], 1974
62
SM-11 [stimulated rhesus monkey] [13 autoradiographs], 1974
62
SM-12 [stimulated rhesus monkey] [13 autoradiographs], 1974
62
SM-13 [stimulated rhesus monkey] [26 autoradiographs], 1974
62
AR-1 through AR-13 [anesthesia studies] [16 autoradiographs], 1974-1975
63
CR-1-5, 101-105; CB-4-7, 9; CRF-201; C02 5 percent [22 autoradiographs], 1974-1976
63
CRF-2-15, 101-105, 111-115 [33 autoradiographs], 1974-1975
63
FD1 [1 radiograph], 1975
63
GBL-12 through GBL-15 [4 autoradiographs], 1975
63
GL1 Cat [8 autoradiographs], 1975
63
MTZ-2 [2 autoradiographs], 1975
63
PEN-1 through PEN-3 [penicillin seizure studies] [3 autoradiographs], 1975
63
Pen Cat-1 [8 autoradiographs], 1975
63
SLC-1 through SLC-2 [15 autoradiographs], 1975
63
SM-14 [stimulated rhesus monkey] [16 autoradiographs], 1975
63
SM-15 [stimulated rhesus monkey] [22 autoradiographs], 1975
63
SM-16 [stimulated rhesus monkey] [32 autoradiographs], 1975
63
SM-17 [stimulated rhesus monkey] [29 autoradiographs], 1975
63
SM-18 [stimulated rhesus monkey] [23 autoradiographs], 1975
64
SM-19 [stimulated rhesus monkey] [19 autoradiographs], 1975
64
SM-20 [stimulated rhesus monkey] [16 autoradiographs], 1975
64
SM-21 [stimulated rhesus monkey] [20 autoradiographs], 1975
64
SM-22 [stimulated rhesus monkey] [22 autoradiographs], 1975
64
WB-6-10, 13, 19 [13 autoradiographs], 1975
64
KSA-101-102, 104-111; KSH-1 through KSH-10; KSM-101 through KSM-102 [Kety-Schmitt assay] [16 autoradiographs], 1975-1976
64
LSD-DG-1-4, 1-13, 101-105, 151-153, 201-205, 301-305, 301-303, 401-407, 501-504, 601-603, 701 [57 autoradiographs], 1975-1976
64
MR, MA, MN, NAL, OIL -- experiment documentation, 1975-1976
64
MR-1-8, 101-104, 202-204; MA-2 through MA-6; MN-1 through MN-6; NAL-1 through NAL-6; OIL-1 through OIL-2 [morphine active chronic -- naloxone] [45 autoradiographs], 1975-1976
65
REM Cat-1 through REM Cat-3 [23 autoradiographs], 1975-1976
65
End-1 through End-12 [endorphins] [12 autoradiographs], 1976
65
End NC-1 through End NC-6 [6 autoradiographs], 1976
65
IOD Cat-1 through IOD Cat-2 [7 autoradiographs], 1976
65
IOD Cat-1 through IOD Cat-2 [8 autoradiographs], 1976
65
IOD Cat-3 [9 autoradiographs], 1976
65
IOD Cat-4 [6 autoradiographs], 1976
65
IOD Cat-5 [9 autoradiographs], 1976
65
IOD Cat-6 [8 autoradiographs], 1976
65
IOD Cat-7 [7 autoradiographs], 1976
65
IOD gamma-1 through IOD gamma-13; cold brain [15 autoradiographs], 1976
65
IODO-1 through IODO-6; Antipyrine-1 through Antipyrine-6 and trial [13 autoradiographs], 1976
65
NBM-1 [new born monkey] [18 autoradiographs], 1976
65
NBM-2 [new born monkey] [16 autoradiographs], 1976
65
NBM-3 [new born monkey] [15 autoradiographs], 1976
65
NBM-4 [new born monkey] [15 autoradiographs], 1976
65
NBM-5 [new born monkey] [16 autoradiographs], 1976
65
NBM-6 [new born monkey] [17 autoradiographs], 1976
65
NBM-7 [new born monkey] [17 autoradiographs], 1976
65
NBM-8 [new born monkey] [17 autoradiographs], 1976
65
NBM-101 [new born monkey] [22 autoradiographs], 1976
66
Piridine#1 [1 radiograph], 1976
66
REM Cat-4 and SLC-6 [11 autoradiographs], 1976
66
REM Cat-5 -- experiment documentation, 1976
66
REM Cat-5 [7 autoradiographs], 1976
66
SM-23 [stimulated rhesus monkey] [18 autoradiographs], 1976
66
SM-24 [stimulated rhesus monkey] -- experiment documentation, 1976
66
SM-24 [stimulated rhesus monkey] [14 autoradiographs], 1976
66
SM-25 [stimulated rhesus monkey] [15 autoradiographs], 1976
66
SM-27 [stimulated rhesus monkey] [21 autoradiographs], 1976
66
SM-28 [stimulated rhesus monkey] [31 autoradiographs], 1976
66
SM-29 [stimulated monkey] [24 autoradiographs], 1976
66
SM-30 [stimulated monkey] [23 autoradiographs], 1976
66
ADR-1 through ADR-12; PRP-0 through PRP-13; PH-0 through PH-14; L-ALP-3 through L-ALP-6; CSPE-1 through CSPE-4; PPE-1 through PPE-6; PRP and PH-1; SOT-1 through SOT-3; D-PRP-0 through D-PRP-4; L-PRP-0 through L-PRP-4 [74 autoradiographs], 1976-1977
66
D-AMP-1-8, 101, 103-109; L-AMP-1-7, 101-105; HLNC-1 through HLNC-15 [42 autoradiographs], 1976-1977
67
CS-1 through CS-27; D-1; CSO-2; C-DEX-1; DEX-1 through DEX-4 [control saline] [43 autoradiographs], 1976-1979
67
CS, YOH, DEX, PH, D-AMP, PX -- experiment documentation, 1976-1979
67
CS-23; YOH-1 and 14; DEX-5; PH-2 and 6; D-AMP-102; PX-12, 14, 16, 21 [20 autoradiographs], 1976-1979
67
DG-136, 148, 167-168, 172, 174-181, 187-189; Tail-1 through Tail-6 [41 autoradiographs], 1976-1978
67
DG-124-135, 137-138, 142-145, 149-151, 154-158, 163, 165-166, 171, 173; PH9; FRD-3 [38 autoradiographs], 1976-1978
67
AR-1 through AR-6, AR-8 [aged rats] [10 autoradiographs], 1977
67
Cat-101 through Cat-105 [39 autoradiographs], 1977
67
CBS-4 through CBS-6; CS-1 through CS-2 [8 autoradiographs], 1977
67
DGX; DG [58 autoradiographs], 1977
67
Fetal sheep -- experiment documentation, 1977
67
Fetal sheep-1 through 6, and 8-13 [14 autoradiographs], 1977
68
Fetal sheep-3 -- experiment documentation, 1977
68
Fetal sheep-3 [10 autoradiographs], 1977
68
Free moving-1 [free moving vs. N20 bag rats] [1 radiograph], 1977
68
Free moving-1 through Free moving-9; N20 bag-1 through N20 bag-8 [free moving vs. N20 bag rats] [26 autoradiographs], 1977
68
HIG-1 through HIG-5 [normal control] [10 autoradiographs], 1977
68
IOD Cat-8 [7 autoradiographs], 1977
68
NC-1 through NC-6 [6 autoradiographs], 1977
68
NO-1 through NO-6; NOF-1 through NOF-6; Free moving-1 through Free moving-8 [nitrous oxide/free moving] [20 autoradiographs], 1977
68
One ear rat [3 autoradiographs], 1977
68
RBAA-18(test) [1 radiograph], 1977
68
RTAA1 [2 autoradiographs], 1977
68
SCD-KCL-1 through SCD-KCL-17; SCD-5; SCD-0-1, 2, 3, and 5; SCD-NACL-1; SCD-OK-1 through SCD-OK-15; SCD-OKF-1; SCD-F-1 through SCD-F-8 [spreading cortical depression] [50 autoradiographs], 1977
68
SM-31 [stimulated rhesus monkey] [20 autoradiographs], 1977
68
SM-32 [stimulated monkey] [22 autoradiographs], 1977
68
SM-33 [stimulated rhesus monkey] [16autoradiographs], 1977
68
SSM-1 [18 autoradiographs], 1977
68
SSM-2 [26 autoradiographs], 1977
68
SSM-3 [17 autoradiographs], 1977
68
SSM-4 [18 autoradiographs], 1977
69
ABS-1 through ABS-4; 1856-5 through 1856-8; Toxin-1, 12-14 [24 autoradiographs], 1977-1978
69
ARC-1 through ARC-8 -- experiment documentation, 1977-1978
69
ARC-1 through ARC-8 [14 autoradiographs], 1977-1978
69
GS-1 through GS-17 [gastric secretion] [51 autoradiographs], 1977-1978
69
Harvard rat-1-7, 10, 13-17 [36 autoradiographs], 1977, 1979
69
MIK-1, 2, 5, 9-10; MAK-1, 6, 8-13; B-1, 2, 5, 7-9, 11-15 [44 autoradiographs], 1977-1978
69
SCD-20-1 and SCD-20-2; SCD-40-1 and SCD-40-2; SCD-M-1 through SCD-M-3; SCD-80-1; SCD-150-1 [spreading cortical depression] [22 autoradiographs], 1977-1978
69
DEX-1 through DEX-5; DEXT-PX-1 through DEXT-PK-5; Ph-8 [dextran] [31 autoradiographs], 1977-1979
70
A-9 [2 autoradiographs], 1978
70
ACL-1, 3, and 4; BCL-1 through BCL-4 [albino/pigmented rats continuous intense light exposure] [14 autoradiographs], 1978
70
ADVS-1 through ADVS-4; BDVS-1 through BDVS-4 [16 autoradiographs], 1978
70
AE, BE, ABE, BBE [albino/pigmented enucleation studies] -- experiment documentation, 1978
70
AE-1 through AE-5; BE-1 through BE-5; ABE-1; BBE-1 [40 autoradiographs], 1978
70
Airbag-1 through Airbag-9 [air bag #8 normal control] [19 autoradiographs], 1978
70
AVS, BVS, ADR, MAK-TI, MAK-II -- experiment documentation, 1978
70
AVS-0-1 through AVS-0-4, AVS-0-11 through AVS-0-14; BVS-0-1 through BVS-0-7; ADR-1 and ADR-11; MAK-TI-1 through MAK-TI-2; MAK-II-2 [45 autoradiographs], 1978
70
Cat Cord 1 (spinal cord and brain) [17 autoradiographs], 1978
70
CL-CT-1 [3 autoradiographs], 1978
70
Dee [36 autoradiographs], 1978
70
DG-182-186, 190-196, 198-199 [28 autoradiographs], 1978
71
Fetal sheep 221 [21 autoradiographs], 1978
71
Fetal sheep 228 -- experiment documentation, 1978
71
Fetal sheep 228 [15 autoradiographs], 1978
71
Fetal sheep 244 -- experiment documentation, 1978
71
Fetal sheep 244 [16 autoradiographs], 1978
71
GRC-10B [1 radiograph], 1978
71
GS-19-20, 22-33, 36-45 [gastric secretion] [75 autoradiographs], 1978
71
GS-27and GS-38 [2 autoradiographs], 1978
71
Lamb-1 through Lamb-2 [11 autoradiographs], 1978
71
MG-64 [2 autoradiographs], 1978
71
MSG-1 through MSG-7 [21 autoradiographs], 1978
72
MSG-6 [2 autoradiographs], 1978
72
NaCl-1 through NaCl-9; MSB-2, 4, 5; DG-170 [saline group] [34 autoradiographs], 1978
72
Phosphate-1 through Phosphate-32 [33 autoradiographs], 1978
72
Rocky-1 through Rocky-32 [stimulated monkey] [38 autoradiographs], 1978
72
SCD-80-1 through SCD-80-4; SCD-80-6 through SCD-80-10 [spreading cortical depression] [18 autoradiographs], 1978
72
SCD-V-1-0; SCD-V-1 through SCD-V-10; SCD-90-11; SCD-OK-21 through SCD-OK-22 [spreading cortical depression] [28 autoradiographs], 1978
72
Space Cat-A and Space Cat-B [2 autoradiographs], 1978
72
Stand VS-S-1 and Stand VS-3 [3 autoradiographs], 1978
72
Windy [33 autoradiographs], 1978
72
YOH-3-7, 10-13 [27 autoradiographs], 1978
72
Zieg-C [2 autoradiographs], 1978
72
ANL-1 through ANL-4; BNL-1 through BNL-4; AVS-1-4, 21-24, 31-34, 41-44; BVS-1-4, 21-24, 31-34, 41-44, 51-54 [85 autoradiographs], 1978-1979
73
APO-7, 13 -- experiment documentation, 1978-1979
73
APO-7, 13 [31 autoradiographs], 1978-1979
73
APO-18-1 through APO-18-7; APO-C through APO-3C -- experiment documentation, 1978-1979
73
APO-18-1 through APO-18-7; APO-C through APO-3C [38 autoradiographs], 1978-1979
73
DG-200-205, 207-217; CK-1 through CK-2 [43 autoradiographs], 1978-1979
73
SCG -- experiment documentation, 1978-1979
73
BDSCG-1 and BDSCG-2; BSDSCG-1 and BSDSCG-2; BD2SCG-1 and BD2SCG-2; BD3SCG-1 and BD3SCG-2 [8 autoradiographs], 1978-1979
73
IHG-1 through IHG-8 [17 autoradiographs], 1978-1979
73
LIDO-1 through LIDO-13 [Lidocaine] [31 autoradiographs], 1978-1979
74
LIDO-1, 2, 5-13 [Lidocaine] [24 autoradiographs], 1978-1979
74
PX-0-9, 13-20, 22 [phenoxybenzomine] [52 autoradiographs], 1978-1979
74
SHR-4 [1 autoradiograph], 1978-1979
74
YOH-14 through YOH-29 [47 autoradiographs], 1978-1979
74
APO-4-1 through APO-4-12 -- experiment documentation, 1979
74
APO-4-1 through APO-4-12 [33 autoradiographs], 1979
74
APO-28-1 through APO-28-6 -- experiment documentation, 1979
74
APO-28-1 through APO-28-6 [27 autoradiographs], 1979
74
Cat- experiment documentation [2 folders], 1979
75
Cold brain w/ hot holes -- experiment documentation, 1979
75
Cold brain w/ hot holes -1 and 2 [7 autoradiographs], 1979
75
DG-206, 216-217 [16 autoradiographs], 1979
75
DX-1 [glycerol perfused brain] [1 radiograph], 1979
75
GC-1 [2 autoradiographs], 1979
75
Gee [32 autoradiographs], 1979
75
Harvard sleep rat-1 through Harvard sleep rat-4 [16 autoradiographs], 1979
75
HY, HYP, HY-CONT, HYR -- experiment documentation [hypoxia (pigmented rats)], 1979
75
HY-1-6, 20-21, 601; HYP-1 through HYP-4; HY-7-9, 10-12, 21-26; HY-CONT-2-4, 6, 7; HYR-1 through HYR-2 [95 autoradiographs], 1979
76
HY-7 [1 radiograph], 1979
76
HY-cont-5 -- experiment documentation, 1979
76
HY-cont-5 [3 autoradiographs], 1979
76
KK-1 [1 radiograph], 1979
76
Milt-1 through Milt-32 [32 autoradiographs], 1979
76
PCP-2 [2 autoradiographs], 1979
76
Reza [25 autoradiographs], 1979
76
Sugar-1 through Sugar-29 [30 autoradiographs], 1979
76
TOE-1 [toe stimulation] [6 autoradiographs], 1979
76
Acid -- experiment documentation (23, 32), 1979-1980
76
Acid-1, 6-9, 16, 20, 22-26, 32-41; NOR-4 through NOR-5; Heart-10 through Heart-12 and Heart-18; CHO-13 [68 autoradiographs], 1979-1980
76
Landau [24 autoradiographs], 1979-1980
76
SCG -- 1A5 through 4A5; 2A10 through 4A10; CA15; 1A15, 3A15, 4A15; 1A20 through 4A20 [15 autoradiographs], 1979-1980
77
Amanda -- experiment documentation, 1980
77
Amanda; Amanda eyes; Amanda spinal cord [31autoradiographs], 1980
77
Atlas-1 [3 autoradiographs], 1980
77
BSL-1 and BSL-3 [2 autoradiographs], 1980
77
Cat 201 [8 autoradiographs], 1980
77
Cat 202 [10 autoradiographs], 1980
77
Cat 203 [10 autoradiographs], 1980
77
CSN-12 [17 autoradiographs], 1980
77
Dreamless -- experiment documentation (3-6, 19-24), 1980
77
Dreamless -test, 2-29 [29 autoradiographs], 1980
77
Marley [37 autoradiographs], 1980
77
N2O-2 and N2O-4 [2 autoradiographs], 1980
77
OLF -- experiment documentation, 1980
77
OLF-1 through OLF-2 [4 autoradiographs], 1980
77
Posh -- experiment documentation (7-10, 13-15, 19-24), 1980
77
Posh -test, 1-10, 13-26 [26 autoradiographs], 1980
77
PRT-2 through PRT-4 [12 autoradiographs], 1980
78
Retina-1 through Retina-3 -- experiment documentation, 1980
78
Retina-1 through Retina-3 [11 autoradiographs], 1980
78
Valium diazepam -- experiment documentation [i.e. VALC, VALL, VALIUM, VAM, VALM], 1980
78
VALC-1 through VALC-8; VALL-1 through VALL-6; VALIUM-1, 2, 4 through 6; VAM-1 through VAM-6; VALM-3 and VALM-7 [70 autoradiographs], 1980
78